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2. SUMMARY. 
Iron deficiency anaemia is perhaps the most widespread nutritional 
deficiency disease; as result, the topic of iron absorption has 
received intensive investigation over a relatively long period of 
time. Most of the investigative thrust has come from clinical 
medicine and allied fields, with some associated biochemical 
investigation. Evidence from the latter has pointed towards the 
involvement of iron-binding proteins especially ferritin and 
transferrin in the absorptive process. While the biochemical 
literature on these two proteins, particularly transferrin, is 
vast, their roles in iron absorption are obscure. This study was 
undertaken, therefore, as an investigatidn into the•e proteins, 
their quantitation and role in iron absorption. The physiology of 
absorption was studied by injection of radiolabelled ferrous 
· ascorbate into isolated intestinal loops and the determination of 
mucosal, blood and carcass uptake. Uptake ~ by the 
mucosa was found to be uniform throughout the intestine wheieas 
absorption (carcass uptake) showed a steep gradient from duodenum 
to ileum. Absorption was shown to increase in states of iron 
deficiency and stimulated erythropoeisis and to decrease in iron 
loading, in all cases ceasing after 30-60 minutes, the total 
amount increasing only slightly thereafter. Prolonged exposure of 
distal jejunal and ileal mucosa to iron did not result in an 
increase in absorption. Absorption increased linearly with 
increasing iron dose, was partially inhibited by cyanide and was 
totally inhibited by the cytoskeletal poisons colchicine, 
vincristine and cytochalasin-B. Isolated cells in vitro showed a 
similar uptake pattern, which was found to be 
temperature-dependent, non-saturable and only partially inhibited 
by cyanide. These results are consistent with a time-dependent 
mechanism of pinocytic uptake. 
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Fractionation of the mucosa by isopycnic density gradient 
centrifugation showed the presence of two iron-binding proteins, 
identified by gel filtration, electrophoresis and radioimmunoassay 
as transferrin and ferritin. The presence of a low molecular 
weight iron compound less than 10000 daltons in the cytosol was 
noted. Further investigation by gel filtration and 
immunoabsorption showed that there were no other iron-binding 
components. Ferritin was found in three-fold greater amounts in 
the iron-absorbing regions of the intestine and iron loading by 
the protein correlated with absorption; iron loading was absent in 
distal jejunum and ileum and also after pretreatment of the mucosa 
with the cytoskeletal poisons colchicine, vincristine and 
cytochalasin-B. Absolute amounts of the protein increased in 
iron~loaded ~tates and decreased in iron-deficient states and in 
all cases ferritin loading increased over time. Prolonged 
exposure of ileal mucosa did not result in ferritin loading except 
in the case of iron loaded animals. Homogenisation of cells in 
the presence of excess iron showed ferritin to be accumulating the 
metal: the radiolabelled ferritin density gradient peak shifted to 
maximal ferritin density without displacement of the radiolabel. 
Transferrin was found in equal quantities and showed similar 
iron-loading behaviour throughout the intestine. Density gradient 
fractionation showed the protein to be present in both free and 
membrane-associated forms; the concentration of the latter, 
approximately 10% of the total transferrin in normal iron 
absorbing cells, was found to correlate with absorption, 
suggesting that it may play some role in the absorptive process. 
Increased amounts of transferrin were found in iron deficiency; 
parenteral iron loading had no effect on transferrin levels. 
Cytoskeletal inhibitors had no effect on free transferrin loading, 
although the membrane-associated transferrin was significantly 
reduced. Administration of a macromolecular iron source, iron 
-s 
polymaltose, in the loop and subsequent fractionation of the 
mucosa, resulted in minimal uptake of iron by transferrin, in 
spite of ferritin loading. These results suggest that 
iron-binding by free transferrin might be an artefact of the 
homogenisation process. Investigation of the contribution of 
serum transferrin to the mucosal transferrin concentration by 
injection of iodinated biologically screened transferrin indicated 
that approximately 24% of the transferrin in the mucosa could be 
accounted for as serum-derived; the remainder was inaccessible to 
proteolytic digestion of whole cells. 
During the course of the study, it was noticed that transferrin 
from mucosal homogenates showed a highly significant immunological 
difference to that of the serum. This difference could not be 
attributed to proteolysis or technical artefacts. "Mucosal" 
transferrin was therefore purified by rivanol extraction, ammonium 
sulphate precipitation and ion-exchange chromatography. The 
last-named procedure separated two transferrins. Electrophoresis 
in 6•8% polyacrylamide gels with 1% sodium dodecyl sulphate , showed that 
one of these species corresponded to serum transferrin, while the 
other was of greater molecular size. Electrophoresis of serum 
transferrin showed no evidence of this larger species. The 
difference was not related to iron-binding, shown by addition of 
iron to transferrin in vitro and subsequent analysis and also by 
the parallel migration of the two transferrins on 
isoelectrofocusing. It is thus possible that this larger 
transferrin species represents a structurally different protein. 
This study, therefore, has succeeded in determining and 
quantitating the iron-binding proteins of the mucosa. However, 
principally due to problems such as the cross-contamination of 
fractions and the failure to identify a high-flux iron 
compartment, a definite conclusion as to the exact nature of the 
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transport and regulation of iron absorption cannot be reached. 
The results are consistent with an hypothesis of pinocytic means 
of uptake and transport in which transferrin may or may not be 
involved. The free diffusion of low molecular weight chelates 
thus seems to be ruled out since this should be independent of 
cytoskeletal activity. Ferritin does not appear to play a direct 
role in the absorptive process, although iron loading by this 
protein, wherever this might occur, would appear to be sited near 
the crucial point in absorption. The role of transferrin, and in 
particular the role of t~e "mucosal" transferrin, in absorption is 
uncertain. Further work into the structure and function of this 
mucosal species will have to be conducted. 
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3. INTRODUCTION. 
Iron is required by all living organisms, and it has ·been said 
(Neilands 1972) that "life in any form without iron is, in all 
likelihood, impossible•. Iron is capable of existing in a variety 
of oxidation states, of which the FeII and the FeIII are the most 
common, and the only forms in which the aqueous ions are stable. 
FeII salts when dissolved in wate~ give rise to a pale green 
weakly acidic aquo-ion, with Ka=-9.5 and a maximum solubility at 
pH 7 of 10-1M. · Similar salts of FeIII are,however, extensively 
dissociated, with a Ka of -3.0 and a maximum solubility at pH 7 of 
10-18M. The hydrated FeIII cation is only able to exist in the 
presence of added acid at pH<l. As the pH rises, protons are 
removed, the FeIII salts undergo further hydrolysis and form 
polynuclear aggregates in which the iron atoms are linked by 
hydroxo bridges. If further base is added, polymerisation may 
occur, with the formation of a colloidal gel of •ferric hydroxide" 
(Phipps 1976). 
At the time of the evolution of the earliest biomolecules, the 
earth's atmosphere was strongly reducing, with the result that 
iron was readily available in the soluble FeII form. Iron was, as 
it is today, extremely abundant, being the fourth most abundant 
element in the earth's crust, and possesses very useful chemical 
properties, being able to alter oxidation state rapidly and 
reversibly. A combination of these factors led to the metal's 
incorporation into the biomolecules. However, with the advent of 
photosynthetic plants, the partial pressure of oxygen in the 
atmosphere rose. Environmental iron was thus oxidised to the 
highly insoluble ferric form, where it is present largely as 
insoluble hydroxides and sulphides. This presented a dual problem 
to living organisms: the acquisition, necessitating solubilisation 
of iron from the environment, followed by the necessity for 
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maintaining the iron, once acquired~ in soluble form. Different 
groups of organisms have solved the problems in different ways. 
Microorganisms have evolved iron scavenging molecules, the 
siderophores, which are secreted into the environment. These 
molecules are found in a wide variety of microorganisms, including 
bacteria and certain species of blue-green algae (Neilands 1972). 
The siderophores, or siderochromes as they are sometimes known, 
are among the strongest chelators of iron known; they are 
hexadentate ligands containing hydroxamate or phenolic binding 
groups. They act by wrapping themselves tightly around FeIII, 
leaving no room for hydrolysis and are taken up again by the 
organism by a mechanism involving binding to cellular receptors 
and internalisation of the complex, and the subsequent release of 
the iron. Whether microorganisms have the capacity for iron 
storage is not certain, but recently iron-protein complexes with 
properties very similar to ferritin have been found in Escherichia 
coli and Azotobacter vinelandii (Harrison et al 1981). Whether 
these organisms have the capacity to excrete iron is not known; 
however, they do increase secretion of siderophores into the 
environment in the case of iron deficiency (Morgan 1981). 
The majority of multicellular organisms have a degree of 
structural complexity restricting the free exchange of nutrients, 
including iron, with the environment, and therefore necessitating 
the development of a circulatory system. Because of the 
insolubility of iron at physiological pH, a carrier is required. 
In plants, this function is served by small organic chelates. 
Plants require a continuous supply of iron as much of the metal is 
lost with the leaves. The only source is from the soil where it is 
present, again, in insoluble form. Plants have coped with the 
problem in a number of ways, principally by the secretion ~f 
organic acids into the soil to solubilise the iron which can then 
-9 
be taken up in low molecular weight form through the roots (Morgan 
1981). Some plant root nodules may in fact secrete 
siderophore-like compounds that deny iron to pathogenic root fungi 
thereby increasing the plant's yield of iron. The iron storage 
protein, ferritin, has been demonstrated in higher plants (Hyde et al 
1962), where it is called phytoferri~in. The literature of 
iron metabolism in certain species of mammals, particularly Rattus 
and Homo, is vast; literature on other species and groups of 
animals is relatively scanty. Furthermore, because of the 
variation in experimental aims and techniques used, it is 
difficult to compare results, and very few studies have concerned 
themselves with comparative iron metabolism. Animals, because of 
the high degree of structural complexity; have evolved a class of 
very high affinity iron-binding proteins, the transferrins, that 
serve as carriers of iron and also for the denial of iron to 
pathogenic organisms. Transferrins have been found in all 
vertebrate species in which their presence has been investigated, 
and transferrins are now being discovered in invertebrates as well 
(Huebers et al 1982). Animals acquire iron in foodstuffs of 
either plant or animal origin. The latter are geneially better 
absorbed, as compounds in vegetable material, principally 
phosphate and phytate, bind the iron and reduce its 
bioavailability, whereas in food of animal origin, most of the 
metal is present in iron-porphyrin complexes which are absorbed as 
such (see below). The iron is solubilised by digestive enzymes, 
and in mammals, by the hydrochloric acid of the stomach. 
Relatively little is known of iron balance in invertebrates, and 
what studies there are are not quantitative. Mammals have been 
the most extensively studied, and consideration of iron balance 
has tended to depend on the observation of Mccance and Widdowson 
(1937) that the excretion of iron, in man, is very limited. The 
necessary corollary to this is that body iron balance depends on a 
-10 
mechanism of regulated absorption. Iron loss in man occurs 
largely through sloughing off of intestinal mucosal cells which, 
like all cells, contain iron, principally in the iron storage 
forms, ferritin and haemosiderin. However, the actual amount of 
iron lost does seem to vary from species to species, being 
apparently higher in rodents (Conrad et al 1964). 
The amount of iron in the human pody ranges from 2-6g, with an 
average of approximately 4g (Moore 1960). Most (approximately 
65%) is present in the haemoglobin of circulating red cells, the 
remainder is present largely in the non-erythroid tissues as the 
storage forms, ferritin and haemosiderin, and a small, though 
essential, 1% is present in the transferrins, the cytochromes and 
iron sulphur proteins, and myoglobin (Crichton 1973). There is 
continual turnover of red cells and tissue proteins so that the 
iron in the body is in a continuous state of flux. The carrier 
involved in this system is transferrin. Approximately half of the 
body's transferrin is in the plasma and the remainder circulates 
through the extravascular fluid (Morgan 1974) • . Iron can leave the 
plasma by two routes: one leads to the erythroid tissue, 
principally the erythroid marrow, where the iron is taken up by 
maturing reticulocytes for haemoglobin synthesis. All of this 
iron will eventually return to the plasma either as result of 
destruction of red cells at the end of their lifespan, or 
following intramedullary catabolism of erythroid cytoplasm (Cavill 
and Ricketts 1981). The former is accomplished by the 
reticuloendothelial system, responsible for breaking down of red 
cells and the catabolism of their haemoglobin. This iron is then 
passed to transferrin and recycled, although some may be stored in 
the reticuloendothelial storage sites (Cavill and Ricketts 1981). 
The second pathway, less defined than the first, is passage of 
iron to non-erythroid tissue, which appears to be mediated through 
the extravascular circulation (ibid). Iron is present in all 
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non-erythroid tissues as storage compounds and enzymes. The metal 
is acquired by the body from absorption through the intestinal 
mucosa, and there is limited means of excretion, a fact recognised 
by Mccance and Widdowson (1937) who stated: "There are indeed 
indications that in man and certain animals the bowel excretes 
practically no iron. If this is the case, the amount of iron in 
the body must be regulated by controlled absorption•. It follows, 
therefore, that the intestine receives information concerning 
deficiency or surfeit of iron and by means of sensory or effector 
mechanisms it acts in response to this information (Moore 1960). 
3.1. Iron in the Gastrointestinal Tract 
Iron enters ihe gastrointestinal tract · bound to various foodstuffs 
of either animal or vegetable origin, from which it is released by 
the enzymes and hydrochloric acid .of the stomach. This highly 
acidic environment also serves to maintain the iron in solution, a 
function that may be assisted by the presence of a high molecular 
weight iron-binding mucopolysaC"Charide which has been reported in 
gastric juice (Turnbull 1974). Once out of the stomach and passing 
into the intestine, however, the pH of the food material rises 
steadily. It is very well documented that FeII is better absorbed 
than FeIII (Brise and Hallberg 1960). This was at first thought 
to be due to an intrinsic advantage of ferrous over ferric iron 
(Bothwell and Finch 1962); however, the importance of iron 
solution chemistry has increasingly been realised, and that the 
greater solubility of the FeII form may simply be due to the 
greater solubility of this ion at pH's approaching neutrality. It 
has in fact been demonstrated that FeIII iron, provided it is 
maintained in solution, is as well absorbed as its FeII 
counterpart (Spiro and Saltman 1969). In this more alkaline 
environment, the iron may either be hydrolysed, forming ferric 
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hydroxide polymers which are not available for absorption or 
combine with any of a variety of ligands present. These complexes 
may or may not be available for absorption. It is known that 
inorganic iron is more efficiently absorbed than iron of animal 
origin which is in turn better absorbed than iron of vegetable 
origin. 
such as 
The last-named is due largely to the pr~s~nge of compounds 
(Cowan et al 1966) 
oxalate, phosphate and particularly phytate,....._which combine 
with the iron and reduce its solubility (Forth and Rummel 1973; 
Peters et al 1971). On the other hand, certain compounds enhance 
absorption. These are generally chelates that serve to keep the 
(Conrad and Schade 1968) 
iron in solution: ascorbic acid, citric acid, fructose and other 
(Davi~ a·,d Deller 1967) ~ 
sugars~ The ettect ot ascorbic acid is thought to be due to the 
reduction of the iron and the formation of the soluble ferrous 
ascorbate chelate (Conrad and Schade 1968). Certain amino ·acids, 
(Van Campen 1973) 
e.g. histidine, cysteine and lysine, also enhanca absorption~This 
enhancement is abolished by decarboxylation, further evidence that 
efficient absorption depends on the presence of soluble chelates 
(Van Campen 1973). Synthetic chelates such as EDTA and 
desferrioxamine, however, form stable, charged iron complexes that 
are not available for absorption, if present in excess. 
None of these compounds affects the absorption of haem, however. 
It has been shown (Conrad et al 1966) that the haem complex is not 
split but is absorbed as such. A specific haem receptor has been 
identified and characterised on brush border microvillous membrane 
(Grasbeck et al 1982), the haem-receptor complex is presumably 
then absorbed by endocytosis and the iron split off only inside 
the cell by a microsomal haem oxygenase. An interesting point is 
that the absorption of haem is low in comparison with that of 
haemoglobin; this has been attributed to the reduced solubility of 
the complex in the absence of globin (Conrad et al 1966a). 
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3.1.1. The Mucosa! Epithelium. 
The control of iron absorption and hence of iron homeostasis in 
mammals rests entirely with the mucosa! cell of the small 
intestine. The small intestine of the rat may be divided into 
three sections: the duodenum, forming the upper 10 cm or so of the 
rat intestine just distal to the pylorus becoming continuous with 
the jejunum, the next two fifths, which is in turn followed by the 
ileum, the remaining three fifths. Intestinal villi project from 
the membrane into the lumen; the villi of the duodenum are broader 
and longer, decreasing gradually in size to a minimum in the ileum 
just before the ileocaecal junction. The villi have cores of 
lamina propria, but no connection to the muscularis mucosa or 
submucosa (Figure 1). Coating the villi are the epithelial or 
mucosa! cells of the intestine. These are tall columnar epithelial 
cells having a thick •striated border• shown by electron 
microscopy to be composed of packed microvilli or projections of 
the luminal membrane. The luminal plasma membrane may therefore be 
described as a •brush border•. The membrane itself is a typical 
trilaminar structure (Kenny and Booth 1976), 8- 10 nm in 
thickness. Thin sections of the brush border frequ&ntly show a 
polysaccharide coat, the glycocalyx or "fuzz" particularly marked 
at the tips of the microvilli. 
The mucosa! cells have abundant cytoplasm, are enclosed on the 
sides by highly convoluted cell membranes and have abundant 
mitochondria, rough endoplasmic reticulum and Golgi apparatus but 
few free ribosomes (Altmann and Enesco 1967). The epithelium in 
the crypts between the villi the crypts of Lieberkuhn-- is 
composed of large numbers of glandular cells with small columnar 
epithelial cells. Electron microscopy shows that these cells are 
poor in cytoplasm, have smooth lateral membranes, few mitochondria 












Figure 1. Three-dimensional drawing of the lining of the small 
intestine, showing the villi and crypts of Lieberkuhn as well as 
the submucosal layers. After Ham (1965). 
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are packed with free ribosomes (Altmann and Enesco 1967). This 
would indicate that these cells are in a relatively 
undifferentiated state and show a high rate of division. 
Epithelial cells on the villi, on the contrary, do not divide. 
Radioautography shows that columnar cells in the crypts migrate u~ 
the villus, appearing on the surface within about l day and after 
about 3 days have reached the villus tip where they are extruded 
(Altmann and Enesco 1967). The mucosal epithelium of the rat is 
thus renewed approximately every 3 days. 
The cores of the villi are composed of lamina propria, consisting 
of connective tissue having many of the attributes of lymphatic 
tissue. A single arterial twig from the submucosa penetrates the 
muscularis mucosa beneath each villus and ascends the latter for 
some distance before breaking down into capillaries. These 
capillaries approach the mucosal cells very closely. Separate 
arterial twigs break up into capillaries surrounding the crypts of 
Lieberkuhn. Smooth muscle fibres extending from the muscularis 
mucosa have their long diameter parallel with those of the villus 
and are located around the lacteal, the single large lymphatic 
capillary of the villus. 
Two phases of iron absorption have been recognised: an initial 
rapid phase, starting within seconds of the presentation of iron 
to the brush border membrane and reaching a maximum within 30-60 
minutes,and a subsequent slow phase lasting up to 24 hours 
(Hallberg and Sollvell 1960; Wheby and Crosby 1963). The 
absorptive process can also be divided, according to the barriers 
presented to the iron, into~ components: uptake across the brush 
border membrane, transfer across the cell and finally release to 
the blood across the serosal surface. The mechanism or mechanisms 
by which these processes occur are not known. 
Effective absorption is dependent in the first instance on the 
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ease with which the compound traverses the membrane (Albert 1973). 
The lipid layers of membrane are a major factor in restricting 
their permeability, and it is well known that lipophilic 
substances tend to pass cell membranes more readily than those 
which are water soluble. Water soluble substances may,however, 
pass through pores in the lipid barrier or by being transported by 
mechanisms that form part of the membrane structure. The mechanism 
by which iron enters the cells may be either active or passive 
(Table 1): characteristics of active transport are, first and 
foremost, a dependence on metabolic energy, inhibition by 
metabolic poisons, partial or complete substrate specificity, 
transport against either a concentration or potential gradient and 
finally saturation of the mechanism at higher substrate levels. 
Passive diffusion on the other hand shows no reLiance on metabolic 
energy, moves molecules down gradients only and will only permit 
the passage of lipophilic molecules through the membrane. Charged 
molecules would be unable to penetrate the membrane due to the 
high energy required to move them from an aqueous to a lipid 
phase. Three ·other cases that do not fall into these two 
categories may be recognised: firstly, the phenomenon of 
facilitated diffusion, a saturable process that can move charged 
species. This does not rely on oxidative metabolism nor is it 
capable of working against a concentration gradient. Secondly, 
when pores exist in the membrane; these allow the passage of 
molecules smaller than albumin (molecular weight 70000 daltons). 
Thirdly, pinocytosis and phagocytosis, cell "drinking" and 
"eating" respectively (Silverstein et al 1977), the former 
concerned with the vesiculation of small particles and the latter 
with large particles such as viruses. 
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3.1.2. Transport across the Brush Border Membrane. 
Most semipermeable membranes do not appear to possess active 
transport mechanisms specific for transition metal ions (May et al 
1978). The alternative, passive diffusion, requires a low 
molecular weight lipophilic complex, as neither high molecular 
- weight proteins nor free aquated ions could enter the cell in this 
manner. 
The requirement for both facilitated diffusion and pinocytosis is 
a specific receptor within the membrane. There is a great deal of 
evidence (see below) concerning the uptake of iron by mucosa! 
cells, much of it conflicting. May et al (1978) have stressed that 
the interpretation of results in a case such as this may be very 
difficult, as all the criteria used to identify the kind of 
transport processes involved m~y be ambiguous. For instance, it 
has been found (Yeh and Shils 1966) that inhibitors of protein 
synthesis inhibit iron absorption: this may be related to ferritin 
or storage iron synthesis within the cell, inhibited synthesis of 
a protein carrier or inhibition of some form of an active 
transport system. A further complication may be that of complex 
formation of the iron: a phenomenon that may cause movement of an 
ion against a concentration gradient and may show typical effects 
of saturation. It is well documented that at low iron doses (less 
than 50 µM) uptake is saturable, whereas at higher doses uptake 
shows first order kinetics (Gitlin and Cruchaud 1962; Thomson and 
Valberg 1972; Wheby et al 1964). Further, changes in species 
distribution between media on either side of the membrane, due to 
differences in composition of pH, may tend to produce a flux for 
reasons that are not easy to discern. A further complication is 
that of changes in oxidation state. The evidence, as mentioned 
above, is conflicting. Early research by Hahn et al (1943) showed 
that the transfer of iron across the intestinal epithelium is 
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Table 1. A brief summary of the major transport processes through 
membranes. Information was obtained principally from Allison and 
Davies (1974) and Silverstein et al (1977). 
Transport 
process 
Metabolic Intact Saturable 
energy cytoskeleton 
Active Yes No Yes 
Passive No No No 
diffusion 
Diffusion No No No 
through pores 
Facilitated No No Yes 
diffusion 










influenced by cell metabolism. Since then, a dependence on 
metabolic energy has been shown repeatedly (Dowdle et al 1960; 
Manis and Schachter 1962; Ruliffson and Hopping 1963; Jacobs et al 
1966; Linder et al 1975) and a number of authors (Dowdle et al 
1960; Manis and Schachter 1962) proposed an active transport 
mechanism specific for FeII, consisting of two steps: rapid 
uptake across the brush border membrane, followed by transport 
across · the cell and slower release at the serosal membrane. There 
is some disagreement about the saturation kinetics of the system 
(Manis and Schachter 1962; Jacobs et al 1966). It is possible 
that this could be due to loss of cellular function which can 
occur when gut sacs are incubated over several hours (Smith et al 
1969). Other workers, have, however, failed to confirm the active 
transport hypothesis (Brown arid Justus 1958; Pearson and Reich 
1965). The active tr~nsport studies are difficult to evaluate, as 
most of them were done on everted gut segments. or whole cells in 
situ, which do not separate the processes of uptake and transport 
or events occurring within the cell, such as protein synthesis or 
mitochondrial uptake, which is known to be energy-dependent 
(Romslo and Flatmark 1973). Studies using isolated brush borders 
(Kimber et al 1973; Savin and Cook 1978) have suggested that 
uptake by the brush border membrane is not energy-dependent. 
Passive transport, either by simple or facilitated diffusion, has 
tended to be the more favoured theory especially in recent years. 
Workers in the mid-sixties (e.g. Saltman 1965; Forth et al 1965; 
Hopping and Ruliffson 1966) stressed the importance of equilibrium 
binding and chelation phenomena: if both FeII and FeIII species 
are available for absorption provided suitable chelates are 
present, the need for metabolic energy is removed. The importance 
of soluble chelates has been observed (Spiro and Saltman 1969); 
Kimber et al (1973) found uptake of iron by brush borders was 
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greater from ferric citrate or ferric ascorbate than from ferrous 
sulphate; similarly Cox and O'Donnell (1981) observed similar 
behaviour. Whether the function of the chelates is simply to 
maintain the iron in soluble form in the gut lumen or whether the 
complex is absorbed as such is not certain. Terato et al (1973) 
found that absorption of iron from chelates was dependent on the 
molecular weight of the compound, which suggested absorption. It has 
been found that the fat soluble and therefore membrane permeable 
chelate ferrocene is almost quantitatively absorbed following oral 
administration (May et al 1978 ). Sex-linked anaemic (sla) mice, 
normally unable to absorb inorganic iron, when fed on a · · 
! ipophilic iron compound showed effective transfer 
of iron from lumen to serum (Edwards et al 1974). Absorption of 
iron from 8-hydroxyquinoline or its sulphonic acid analogue was 
increased by a factor of four (Forth and Rummell 1973); this was 
attributed to the charge on the compound formed. In this respect, 
iron absorption from the synthetic chelate EDTA is interesting: 
iron in EDTA is effectively unavailable for absorption (Jandl et 
al 1959). The complex formed is charged and hydrophilic. 
It would appear, therefore, as though both active and passive 
transport processes have a role to play. The relative importance 
of each is difficult to evaluate. Dowdie et al (1960) suggested 
that the active transport mechanism may come into play if passive 
diffusion is restricted. This would fit the observed differences 
in kinetics at different iron concentrations (Forth and Rummel 
1973). Active transport mechanisms do have role to play in many 
instances, but the principle of energy conservation applies here 
as it applies elsewhere in nature: if such expenditure can be 
avoided, it will be. 
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3.1.3. Intracellular Transport of Iron. 
The second step in absorption is that of transport through the 
mucosal cell. A wealth of information has accumulated on this 
topic, some confusing and conflicting, but a number of general 
trends are apparent. It has been shown that absorption is 
diminished by inhibitors of protein synthesis (Yeh and Shils 
1966); phenobarbitone, a stimulator of protein synthesis 
(Rosenzweig et al 1969) increases absorption (Thomas et al 1972). 
It has been assumed on this evidence that a protein carrier is 
involved, however, as has been described above, the effect of the 
inhibitors may not be direct, affecting perhaps ferritin synthesis 
or that of some oth~r species not necessarily on the direct path 
of absorption. Iron-binding proteins have however been found by 
almost all investigators: the general trend is that of ferritin 
and transferrin or a transferrin-like protein. A summary of these 
investigations is presented in Table 2. 
Using differential centrifugation, Pearson and Reich (1969) found, 
in the rat, evidence of ferritin and a "high molecular weight 
protein other than ferritin". 
Worwood and Jacobs (1971a and b) found, in the rat, most of the 
absorbed iron in the first early phase of absorption to be in the 
cytosol. After 12-18 hours, the mitochondrial fraction was the 
most active however. As far as proteins were concerned, ferritin, 
a protein of MW 80000 and an apparent high molecular weight non-
ferritin protein were found. Evidence of the latter was also found 
on polyacrylamide gel electrophoresis. 
Halliday and Powell (1973) and Halliday et al (1976), in the rat, 
found ferritin, transferrin and a protein similar in molecular 
weight to transferrin but immunologically distinct. Iron was also 
associated with intracellular membrane particles; chaser studies 
-22 
Table 2. The association of radioiron with components of the 
intestinal mucosa during absorption. Table (a) shows studies 
based on subcellular fractionation. Tf = transferrin; Fe= iron; 
G-pig = guinea pig. Table (b) shows studies based on 
autoradiography. 
ER= endoplasmi~ reticulum; 
Mitoch. = mitochondria. 
-----------------------------------------------------------------
(a) Studies based on subcellular fractionation. 
Tf Ferritin Other Species Reference 
Yes Yes Tf-like Rat Halliday and Powell (1973) 
Yes Yes Membrane Rat Halliday et al (1976) 
Yes Yes Low MW Rat Batey and Gallagher (1977) 
Yes Yes Rat Kaufman et al (1977) 
Yes Yes Tf-like Rat Huebers et al (1971,1976) 
No Yes Fe-salts Rat Sheehan and Frenkel (1972) 
Yes Yes Rat Savin and Cook (1980) 
? Yes Tf-like Rat Osterloh and Forth (1981) 
No Yes Tf-like G-pig Pollack and Lasky (1976) 
Yes Yes Low MW Pig Furoguori (1977) 
Yes Yes .. Rat Charlton et al (1965) 
(b) Studies based on autoradiograpby. 
ER Mitoch. Ferritin Species Reference 
Yes Rat Humphrys et al (1977) 
Yes Rat Hopkins and Peters (1979) 
Yes No Mouse Bedard et al (1971) 
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indicated that these particles and the unidentified protein were 
involved in absorption. 
Batey and Gallagher (1977), in the rat, found ferritin, 
transferrin and another protein of lower molecular weight than 
transferrin and immunologically different, that increased in iron 
deficiency. 
Kaufman et al (1977), using differential centrifugation and 
polyacrylamide gel electrophoresis on rat intestinal homogenates, 
found proteins of molecular weight 400000 and 80000 daltons both 
of which were present in the ribosomal-enriched subfraction 
obtained during purification of the microsomal membrane but were 
not identified among the purified membrane proteins. 
Huebers et al . (1971, 1976) in the rat, observed ferritin and a 
protein of similar molecular weight but differing in amino acid 
composition and isoelectric behaviour to transferrin. Similar 
results were reported by Pollack and Lasky (1976) who found that, 
in the guinea pig, this transferrin-like protein was not 
precipitated by serum transferrin antiserum. 
Humphrys et al (1977) using both differential centrifugation and 
radioautography, found a concentration of activity in both the 
soluble fraction and the mitochondria. As regards the latter, they 
concluded that although these organelles would seem to be 
quantitatively important in iron metabolism, they appeared to have 
no direct involvement in iron transport. 
Hopkins and Peters (1979) using density gradient centr~fugation of 
rat intestinal homogenates, similarly reported an association of 
iron with the mitochondria. 
Sheehan and Frenkel (1972) found ferritin which accounted for 
approximately 90% of the observed radioactivity, and apparently 
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free iron salts, the amount of which increased in iron deficiency. 
Savin and Cook (1980) identified and quantitated the .amounts of 
ferritin and transferrin in rat mucosa. No evidence of other 
species was found. 
Osterloh and Forth (1981) reported the presence of a 
transferrin-like protein in the rat, similar in size and structure 
but differing in immunological reactivity. 
The possibility of the involvement of a low molecular weight 
component or components in iron absorption has been suggested in a 
number of models particularly Jacobs (1977) and May et al (1978). 
Such a component would have ease of transfer through membranes and 
the cell and could form a •pool" or reservoir within the cell from 
which the various cellular structures and components could draw. 
These models are attractive and it is known that low molecular 
weight chelators play a role, certainly in vitro, in the transfer 
of iron from transferrin to ferritin (Miller and Perkins 1969). 
The evidence for such a species in iro~ absorption is scanty 
however: the only investigator to report such evidence is 
Furoguori (1977) in the piglet. 
Autoradiographic studies on the other hand have shown a different 
pattern (Bedard et al 1973): rapid uptake of iron at the brush 
border and passage through the terminal web to rough endoplasmic 
reticulum and areas rich in free ribosomes. The iron then passed 
through the lateral cell membrane, the intercellular spaces and 
the epithelial' basement membrane to the vessels of the lamina 
propria. Regardless of iron status, the rough endoplasmic 
reticulum and ribosomes formed the major localisation of iron at 
all stages of absorption. Ferritin, visible by electron 
microscopy, did not appear to play an important role in 
absorption. 
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The respective roles, if any, of the iron-binding proteins in 
absorption remains controversial. There is general agreement that 
ferritin is not directly involved in the absorptive process 
although it might play a role in the regulation of absorption (see 
the Regulation of Absorption, below). There is evidence and 
suggestions (Halliday et al 1976; Huebers et al 1976) that the 
transferrin or transferr~n-like protein is closely involved with 
absorption. The .possibility of low molecular weight compounds 
being involved in absorption has been discussed above. Pinocytic 
transport remains another possibility. There is evidence that 
haem absorption involves binding to a specific brush-border 
receptor (Grasbeck et al 1982) followed by pinocytosis and 
spli~ting of the haem complex within the cell by a muco~al haem 
oxygenase, whereupon the released iron follows the same path as 
for iron salt, subject to the same regulatory factors (Wheby et al 
1970). The possibility of vesicles being involved in transport of. 
iron salts across the brush border membrane and through the cell 
has been suggested (Evans and Grace 1974; Cox and O'Donnell 1981; 
Marx and Aisen 1981). 
3.1.4. Transport across the Serosal Membrane. 
The last step is that of transfer of iron across the serosal 
membrane to the transferrin in the blood. Very little evidence on 
this point exists. Results of in vitro experiments using 
suspensions of free mucosa! cells (Levine et al 1972) suggested 
that transferrin potentiates this process. Other studies however, 
do not support such a conclusion: Wheby and Jones (1963) found 
that absorption continued after the iron-binding capacity of the 
serum had been saturated and Jacobs et al (1966) found that a gut 
segment with an artificial circulation transferred iron rapidly, 
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while Schade et al (1969) found that increasing the amount of 
available transferrin had no effect on absorption. Morgan (1980) 
presented evidence that transferrin probably acts primarily to 
supply iron to the cells and that iron passes from the cells to 
the portal plasma in low molecular weight form. Clinical evidence 
is provided by the disease of atransferrinaemia characterised by 
virtual absence of transferrin; Heilmeyer (1961) describes the 
case of a 7 year old girl with this disorder whose absorption of 
iron was not impaired in comparison with normal children although 
it was lo.w for anaemia. 
3.1.S. The Control of Iron Absorption. 
It is very well documented that absorption of iron rises in 
situations of need such as reduced stores and increased 
erythropoietic activity and diminishes in states of iron 
repletion (Bothwell and Finch 1962). The means by which this 
occurs remains one of the perennial problems of iron metabolism. 
979
) 
.. Bothwell et al (1 • 
The theorie~ that have been proposed may be divided into 3 groups: 
(i) those involving regulation by the mucosal cell; 
(ii) those involving regulation by transferrin and 
(iii) a mechanism of humor al control. 
(i) Firstly, control by the mucosal cell. Hahn et al (1943) 
presented evidence that absorption of iron increased in iron 
deficiency in comparison to normal subjects. Similarly, feeding 
dogs a large dose of iron resulted in depressed absorption of a 
subsequent dose. Hahn et al (1943) proposed the existence of a 
"mucosa block" and the existence of a "mucosal acceptor" for iron, 
"physiological saturation" of which prevented further entry of 
iron through the mucosa into the body. It was suggested that this 
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acceptor might be apoferritin. These ideas were confirmed by 
Granick (1946) who observed that the mucosa of guinea pigs became 
"saturated" a few hours after the administration of an oral dose 
of iron and further absorption was prevented for several days. 
This led him to propose the "mucosal block" theory of iron 
regulation as follows: iron is absorbed in the ferrous form, 
oxidised to the ferric and stored as such in ferritin. An 
equilibrium between ferrous and ferric iron stored in ferritin is 
postulated in the cell, with the cell being in a state of 
"physiological saturation" with respect to ferrous iron. Lowering 
the concentration of serum iron in the blood stream would lead to 
removal of iron, reduced to the ferrous form, from ferritin and 
from the mucosal cell, resulting in a decrease of ferritin in ' the 
mucosa. Only when the ferritin iron was diminished to a point 
where the cell was no longer "physiologically saturated" with 
respect to ferrous iron, would more iron be absorbed by the cell. 
It was later shown, however, (Wohler et al 1957) that absorption 
continues in spite of maximal ferritin levels and Moore (1960) 
discounted the theory altogether for this reason and for others 
including the observation that the large iron dose administered, 
resulting in the "block" observed by Hahn et al (1943) and Granick 
(1946) was highly artificial, the amount of iron present in the 
food being too small to produce such an effect; also, as the size 
of the test dose increases, the total amount of iron absorbed 
increases, and also, that absorption is greater than normal not 
only in states of iron deficiency but also in states of 
accelerated erythropoeisis when tissue stores are high. Further 
evidence is that after mucosal ferritin synthesis was stimulated 
by iron in both normal and iron deficient rats, normal ferritin 
concentrations resulted in the latter, but absorption was still 
and 
greater (Brittin and Raval 1970)~ that ferritin synthesis itself, 
while increased in the iron loaded mucosa, is equal in both normal 
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and iron deficient cells (Cumming et al 1970) and that, in the 
case of animals with turpentine abscesses which reduce absorption, 
incorporation into ferritin was the same as in normal animals, 
indicating that the reduction of absorption was not due to 
diversion of iron into ferritin (Cumming et al 1970). 
Modifications to the theory were proposed by Crosby (1963) and 
Conrad et al (1964): it was proposed that the iron incorporated 
into mucosal ferritin is there not as a stage of absorption but is 
permanently detained there to prevent its absorption, being 
incorporated from the plasma during the cells' development in the 
crypts of Lieberkuhn. This "loading from the rear• is essentially 
a mechanism for the excretion of excess iron. By saturating 
ferritin and iron-carrier mechanisms of absorption, the cells may 
induce a •refractory state• thus inhibiting the acceptance of 
unneeded iron. Crosby (1963) suggested that the disorder of 
haemochromatosis, in which large quantities of iron are absorbed 
resulting in pathological iron overload, may represent a 
genetically~determined lack of the ability to form ferritin in 
cells, so that the passage of iron is _relatively unimpeded through 
the cells. 
The iron status of the mucosa! cell is dependent on iron both from 
the plasma and from the lumen. Parenterally administered iron 
enters the cells from the serosal pole at the time of their 
emergence from the crypts of Lieberkuhn. The actual iron content 
of the mucosa is not increased with loading but is reduced in iron 
deficiency (Richmond et al 1972; Mattli et al 1973). These authors 
found the greatest concentration of iron in the mitochondrial 
fraction. Similar results were reported by Worwood and Jacobs 
(1971, 1972), who showed that Flasma iron is taken up largely by 
the mitochondria and that, in iron deficiency, mitochondrial iron 
is reduced, as is iron-enzyme activity. In iron loading, 
mitochondria are normal. 
\ 
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A second possibility of mucosal cell control rests on the 
assumption of receptors in the brush border membrane. There have 
been various studies showing that brush borders and microvillous 
membranes play an important role in determining the rate and 
specificity of intestinal transport processes, other than iron 
(e.g. Miller and Crane 1961). Both Greenberger et al (1969) and 
Kimber et al (1973) found increased attachment of iron to isolated 
brush borders in iron deficiency; Cox and O'Donnell (1981) have 
isolated a glycoprotein membrane receptor for iron that also 
responds to changes in iron status. 
(ii) It has also been suggested that transferrin may play a role 
in iron absorption regulation, presumably acting at the serosal 
surface of the cell. Clinical data however does not support the 
hypothesis: in humans, increased absorption is found in patients 
in whom haemoglobin, plasma iron binding capacity and transferrin 
saturation were normal (Pirzio-Birolli and Finch 1960); absorption 
was also found to be decreased by increased stores although the 
plasma iron was normal. 
An explanation was suggested by Fletcher and Huehns (1968) based 
on the hypothesis of functional heterogeneity of the binding sites 
of transferrin. The hypothesis suggests that one site of 
transferrin is more directed to the uptake of iron from the mucosa 
and stores and delivery to the marrow, while the other site is 
oriented to delivery of iron to the stores. The mucosal cell could 
thus be informed of the need fqr iron without there being any 
abnormalities in transferrin saturation or plasma iron. Recent 
evidence (see "Transferrin" b,low) suggests that, for uptake of 
iron by reticulocytes at leaijt, this hypothesis is not valid, that 
the binding sites are in fact functionally homogeneous. No 
evidence exists for transferrin site differences or otherwise in 
uptake of iron from the intestine. 
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Levine et al (1972) presented data suggesting that the amount of 
iron-free transferrin available at binding sites at the serosal 
membrane may play a role in regulation, but no increase in 
absorption could be demonstrated after acute intravenous 
administration of unsaturated transferrin. Similarly Morgan (1980) 
presented data suggesting that transferrin in intestinal fluid and 
binding to the mucosa probably functions primarily in supplying 
iron to the cells rather · than as a carrier. 
there are 
(iii) Lastly,~humoral factors, external to the cell itself. The 
. 
search for a hormone promoting absorption has thus far proven 
unsuccessful (Krantz et al 1959; Beutler and Buttenweiser 1960). 
Administration of erythropoeitin incieases absorption (Mendel 
1961) but presumably through its effect on erythroid marrow rather 
than the intestine; similarly hypoxia has been shown to increase 
absorption (Brittin et al 1968), but also presumably because of 
erythropoeitic stimulation (Hathorn 1971). An inhibitor of 
absorption in gastric juice, •gastroferrin", was reported by Davis 
and Deller (1966) but is not confirmed (Jacobs and Miles 1968). 
Confusingly, absorption was apparently increased in rats (Turnberg 
1968) and humans (Murray and Stein 1968) by administration of 
gastric juice from iron deficient subjects. Pancreatic secretions 
have also been proposed (Davis and Badenoch 1962) but not 
confirmed. 
On the strength of this evidence, it appears as though control of 
absorption rests with some sort of mucosa! cell regulation. The 
influence of humoral factors can probably be discounted; the 
evidence is minimal and, at best, contradictory. Similarly, it 
appears as though on the strength of recent demonstrations of the 
functional homogeneity of the binding sites of transferrin and the 
invalidation of the Fletcher-Huehns hypothesis, that this, too, 
can be discounted as a means of control. As far as regulation by 
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the mucosa! cell itself is concerned, it is apparent that, while 
ferritin may play a part in the absorption and regulation of iron, 
it is not the only factor involved. The hypothesis of brush 
border receptors thus appears, on present evidence, to be the most 
acceptable. However, subcellular fractionation studies have 
indicated the presence of transferrin or a transferrin-like 
protein, apparently involved in iron absorption. It is therefore 
possible that the process consists of uptake by the brush border 
receptor, followed by handover to transferrin, perhaps with an 
intervening regulatory step. Present evidence suggests that the 
iron-binding components of the mucosa represent known moieties, 
such as transferrin and ferritin, which would argue for the 
involvement of these in the process. The alternative is a 
completely novel mechanism, a possibility that cannot be 
discounted. 
3.2. Transferrin. 
The transferrins are a group of high affinity iron-binding 
glycoproteins, ·of molecular weight 80000 - 90000 daltons and each 
binding 2 atoms of ferric iron whose functions include the 
transport of iron between sites of absorption, utilisation and 
storage, and the denial of iron to pathogenic organisms (Aisen and 
Listowsky 1980). The transferrins have traditionally been thought 
to exist only in vertebrates and to consist of the three related 
proteins, serum transferrin, lactoferrin and ovotransferrin. 
However, a number of publications in the last few years attest 
that the traditional classification is far too limited: 
transferrins do exist in animal groups outside the vertebrate 
subphylum, as shown by the recent discovery of a transferrin in 
. the crab (Huebers et al 1982), fish transferrins lacking glycans 
have been found (cited Williams 1982) and a number of "new" 
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proteins similar in structure and properties to transferrin have 
been found (e.g. Brown et al 1982; Antanaitis and Aisen 1982). 
Structural variation within transferrin itself is well-known, 
particularly the genetic polymorphism found in many species (Aisen 
and Leibman 1972), as well as the fact that different tissues of a 
single individual may produce •different• transferrins e.g. 
cerebrospinal fluid (Parker and Bearn 1962) and the Sertoli cells 
of the testis (Skinner and Griswold 1980). The classification · of 
the group thus appears considerably more complex than at first 
thought. 
The transferrins consist of a single polypeptide chain of 
molecular weight about 80000 daltons (Greene and Feeney 1968) that 
folds up into 2 compact globular structures or domains (Gorinsky 
et al 1979). Each domain has a specific binding site for one · 
ferric atom and are generally thought to be independent although 
Aisen et al (1973q.. have suggested that there may be some 
interaction. The domains are formed from the N and C terminal 
halves of the protein and have been isolated after partial 
proteolysis as single chain iron-binding fragments of molecular 
weight about 40000 daltons each (Williams 1974). The two halves of 
the polypeptide chain are homologous: it has been shown 
(MacGillivray et al 1977; Jeltsch and Chambon 1982; Williams et al 
1982.q.., that about 40% of the residues are identical. The domains 
also have similar iron-binding properties, with the same ligands 
involved in binding in each case (see later). There are however 
spectroscopic differences which may be caused by different 
geometries at each site and the distribution of iron between the 
two is not random (Lestas 1976; Princiotto and Zapolski 1976). 
The observed homology may be confirmation of an hypothesis 
suggested by Greene and Feeney (1968) that the two domains are 
descendants of a common ancestral protein and that gene 
duplication and fusion during evolution led to the present-day 
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structure. After fusion, the two domains diverged both in 
structure and iron-binding properties. Although the two domains 
do show some physical differences (see below), present evidence 
indicates that there is no difference in the in vivo behaviour of 
the sites with respect to iron uptake and delivery to cells. This 
hypothetical ancestral protein is supposed to have had a molecular 
weight of around 40000 and suggestions that this protein was 
itself derived from an ev_en smaller prote'in have also been made 
(MacGillivray et al 1977; Jeltsch and Chambon 1982). A search for 
the 40000 dalton ancestral transferrin led to the finding in the 
hagfish Eptatretus stoutii, a primitive vertebrate (Palmour and 
Sutton 1971) of a 40000 molecular weight transferrin; however, 
Aisen et . al (1972) we~e unable to confirm this, and indeed wrote 
in a later paper (Aisen and Listowsky 1980) "Why a two-sited 
protein should possess biological advantages enabling it to endure 
to the exclusion of its single-sited ancestor remains a mystery to 
transferrin biochemistry". The answer to this question lies in the 
problem of renal excretion of serum proteins: proteins of 
molecular weight less· than about 70000 (the molecular weight of 
albumin) are able to pass through the glomerular membrane and thus 
are excreted (Brenner and Rector 1981). Williams et al (1982) have 
in fact demonstrated the excretion of isolated domains (molecular. 
weight ca. 40000 daltons) of serum transferrin from the kidney 
tubule. If indeed, the ancestral protein was as small as this, it 
seems unlikely to have been retained in the blood; there would be 
strong selective pressure to enlarge it while retaining its highly 
useful functional characteristics. A low molecular weight 
membrane-bound glycoprotein which appears to be homologous to a 
single domain of immunoglobulin has recently been discovered 
(Cohen et al 1981). By analogy, Williams et al (1982) have 
postulated that the ancestral transferrin may have been a 
membrane-bound metal receptor protein. Ancestral transferrin may 
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have followed a similar evolutionary pathway. In this respect, it 
-
is interesting that p97,MW 97000, a membrane tumour antigen found in 
melanomas and foetal intestine, is homologous to transferrin and 
binds iron (Brown et al 1982). P97 could represent an intermediate 
stage, a "missing link", in the evolution of transferrin. 
3.2.1. Structure of Transferrins. 
For a comparison of the different transferrins isolated to date, 
see Table 3. 
The molecular weight of transferrins, and in particular that of 
serum transferrin, has been variously reported as ranging from 
70000 to 90000 daltons, with more recent estim~tes (e~g. 
MacGillivray 1977) inclining to a figure between 80000 and 81000. 
However, MacGillivray et al (1982) in a complete amino acid 
sequence analysis, has set the figure at 79550, containing 678 
amino acid residues. The single polypeptide chain is divided into 
2 domains, as described above, corresponding to residues 1-336 and 
337-678, each bearing an iron-binding site and are apparently 
homologous. Transferrin contains approximately 6% carbohydrate in 
the form of two nearly symmetrical branched heterosaccharide 
chains of molecular weight ca. 2200 daltons each (Dorland et al 
1977). These two chains were previously thought to be identical, 
but recent investigation (Spik and Mazurier 1977) has shown that 
they differ. Both chains are located on the c-terminal- region of 
the protein, and are joined by p-1 glycosidic linkage to 
asparagine residues 415 and 608 (Jamieson et al 1971; MacGillivray 
et al 1977). It is interesting that this pattern is conserved in 
other transferrins: in chicken ovotransferrin, both glycosylation 
sites are also present in the C-domain (Kingston and Williams 
1975). While the amino acid sequence of the polypeptide chain is 
genetically coded and determined by the usual template mechanism, 
Table 3. Members of the transferrin class that have been 
discovered to date. *MW: molecular weight. 
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Transferrin Source MW* Sites for Reference 
iron 
Mamaalia 
Transferrin Human 79550 2xFeIII MacGillivray et al (1982) 
serum 
Lactoferrin Milk; 80000 2xFeIII · Leibman and Aisen (1972) 
secretions 




80000 2xFeIII Skinner and Griswold (1980) 








? 2xFeIII; Ananaitis and Aisen (1982) 
plus 
phosphatase 
81000 2xFeIII Greene and Feeney (1968) 
Transferrin Turtle 96000 
Amphibia 







72000 ? Palmour and Sutton (1971) 
81000 2xFeIII Van Eijk et al (1972) 
78000 ? Got et al (1967) 
Transferrin Hagfish 76000 2xFeIII Aisen et al (1972) 
Arthropoda 
Transferrin Crab 150000 2xFeIII Huebers et al (1982) 
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the carbohydrate residues are added at post-translational level 
only, directed by transferases (Gottschalk 1969) which may result 
in heterogeneity of the carbohydrate groups. Variations in the 
primary structure, as seen in human transferrin polymorphism, are 
caused by mutations at a single autosomal locus (Alsen and Leibman 
1972). Thus two transferrin species in different tissues of a 
single individual may show variation in carbohydrate, while the 
amino acid backbone is identical; this is seen in the hen with 
serum transferrin and ovotransferrin or conalbumin (Williams 1962) 
and in the human, with serum transferrin and cerebrospinal fluid 
transferrin where the same situation prevails. The function of the 
carbohydrate chains are unknown, although it has been suggested 
(Van Bockxmeer and Morgan 1977) that acylation of the 
carbohydrate groups may be involved in the binding of the protein 
to its cell surface · receptors (see later). 
Lactoferrin, also known as lactotransferrin, the •red protein• of 
milk and other secretions, has so far been found only in mammals. 
Lactoferrin, although clearly homologous to transferrin, differs 
-
both in polypeptide and carbohydrate structure (Aisen and Leibman 
1972), does not cross-react immunologically and thus may be 
thought of as a separate gene product. It is present in normal 
human serum at concentrations of about 3 mg/1 (Bennett and Mohla 
1976) but whether it plays any role _in the transport of iron is 
not known; it has been suggested (Morgan 1981) that the protein 
may be involved in iron transport from plasma to 
reticuloendothelial cells and may thus contribute to the reduction 
in plasma iron concentration that occurs in acute imflammatory 
states. A further function of lactoferrin is that of defence 
against bacterial infection, by "mopping up• surplus iron that 
might otherwise be utilised for the proliferation of 
microorganisms, a function also attributed to transferrin itself. 
A third possibility is that of control of iron absorption: Cox et al 
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(1979) found specific lactoferrin receptors in human duodenal 
brush-border membrane. Recently, two further proteins have been 
discovered that appear to have characteristics of transferrin and 
may thus be tentatively included in the discussion of the class. 
p97, a protein of molecular weight 97000 daltons, is a membrane 
protein found only in trace amounts in normal tissue. It has 
recently been purified and characterised from human melanoma cells 
(Brown et al 1982) and its N-terminal sequence shown · to be 
homologous to the respective sequences of transferrin and 
lactoferrin. Denatured p97 was shown to cross-react 
immunologically with both denatured transferrin and lactoferrin. 
Its function appears to be that of transmembrane iron transport 
(ibid). 
Uteroferrin, a purple progesterone-induced glycoprotein with 
phosphatase activity, is secreted by the pregnant porcine uterus 
Placentation in the pig i~ of the epitheliochorial type, where 
there is no invasion of maternal tissue by the developing 
trophoblast, so that the latter is dependent on the secretion of 
nutrients by the mother. Uteroferrin forms a major constituent of 
these secretions, binds two atoms of iron (Antanaitis and Aisen 
1982) and is capable of transferring iron to transferrin in utero 
(Buhi et al 1982). It has thus been postulated that the major 
function of this little-known protein is that of transplacental 
iron transport (ibid), the other being its known phosphatase 
activity. 
The transferrin membrane receptor is a topic that has received 
much attention in recent years. Receptors have been found in a 
variety of cells, but are particularly abundant in cells requiring 
large amounts of iron such as cells of the erythroid marrow and 
the placenta. Active reticulocytes can incorporate over lxl06 
atoms of iron per minute. These cells have approximately 300000 
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transferrin receptors (Williams 1982), and the transferrin 
binding, internalisation, release of the iron and return of the 
apotransferrin to the medium takes place within 15 - 30 seconds 
(Newman et al 1982). Other types of tissue in which transferrin 
receptors have been found include the placental trophoblast 
(Galbraith et al 1980a and b), fibroblast, lymphocytes, kidney 
tissue, epithelia, various tumour cells (Larrick and Cresswell 
1979) and haemopoeitic progenitor cells (Sieff et al, cited Newman 
et al 1982). The literature on the reticulocyte receptor and 
receptor-transferrin interaction is vast and will be discussed in 
detail under functional aspects of binding sites (see below). The 
receptor has been puri{ied and characterised: there is one 
ubiquitous receptor throughout all tissues; it is a glycoprotein,· 
a dimer of molecular weight 150000 (Van Bockxmeer et al 1975), 
180000 (Ecarot-Charrier et al 1980) or 213000 (Enns and Sussman 
1981) with subunits each 90000 - 94000 daltons (Seligman et al 
1979). The latter authors reported a molecular weight of 364000 
for the transferrin-receptor complex; the receptor, therefore, 
binds two molecules of transferrin. Much of the work on the 
receptor has been done with the aid of monoclonal antibodies which 
have been used to isolate ~nd identify the receptor. Trowbridge 
and Omary (1981) reported that monoclonal antibody 83/25 raised 
against a human erythroid leukemia cell line was directed against 
the transferrin receptor; Sutherland et al (1981) found that 
monoclonal anti-T cell reagent OKT9 was also directed against the 
receptor. The receptor possesses N-asparagine-linked carbohydrate 
chains, and it has been reported (ibid) that it contains 
high-mannose chains and one complex chain, an unusual 
configuration. The receptor also possesses phosphoryl serine 
residues and covalently bound fatty acid (Newman et al 1982). 
The receptor is solubilised with detergents and is readily 
labelled with lipophilic nitrene reagents, sugge~ting that it is 
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an integral membrane protein, and since phosphoryl serine residues 
are not present in the trypsin-cleaved fragment, it may also be a 
trans-membrane protein. Owen et al (1980) used a different method, 
that of protease digestion of microsomes, and were able to 
demonstrate that the receptor is in fact a trans-membrane protein, 
having a trans-membrane tail of about 5000 daltons. An · 
interesting point is that the genes for transferrin itself and its 
receptor, both molecules of very similar size, are located on the 
same chromosome, chromosome 3 (Williams 1982). 
3.2.2. Iron Binding by Transferrin. 
Transferrin binds two Fe 3+ atoms tightly but reversibly; the 
equilibrium constant for the two binding sites at physiological pH 
' is of the order of 1030 (Aasa et al 1963). Apart from iron, the 
protein also binds a variety of divalent and trivalent metal and 
rare earth cations (Perkins 1966; Ford-Hutchinson and Perkins 
1971), although the highest affinity i& for the Feill ion (Warner 
and Weber 1953). Transferrin does not, however, bind Fell or at 
least only very weakly (Bates and Schlabach 1975). A 
characteristic of the iron-binding process is the requirement for 
an anion; at physiological pH this is usually carbonate or 
possibly bicarbonate (Bates and Schlabach 1975; Price and Gibson 
1972); others such as oxalate, nitrilotriacetate and thioglycolate 
may also bind; inorganic anions do not. Both the anion and the 
metal bind cooperatively in a 1:1 ratio with the protein, neither 
binding appreciably without the other. Metal binding itself 
involves two or three tyrosyl (Tan and Woodworth - 1969) two 
histidyl (Line et al 1967) and an equal number of tryptophanyl 
(Tan and Woodworth 1970) residues. Electron paramagnetic resonance 
evidence indicates that oxygen and four nitrogen nuclei interact 
with the metal (Aasa and Aisen 1968). The anion is itself bound to 
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the protein,a phenomenon resulting in the characteristic 
salmon-pink colour of the iron-complexed protein (Jamieson et al 
1971). EPR studies have found the minimum possible distance 
• between the binding sites to be 9A (Aasa et al 1963); a similar 
0 
study using fluorescence (Luk 1971) found this to be 43A. 
Conformational changes occur with the binding of iron: diferric 
0 
transferrin is a prolate ellipsoid with a major axis of 55.2A, a 
minor axis of 27.6A and a hydration volume of 16.9xl0-20 cm3 
(Rosseneu-Motreff et al 1971), in contrast to the apoprotein's 
0 • 
major axis of 62.0A, minor axis of 24.6A and hydration volume of 
15.4x10-20cm3 (Rosseneu-Motreff et al 1971). Furthermore, iron-
binding reduces hydrogen-tritium exchange, indicating a more 
folded state, and nuclear magnetic resonance changes are apparent 
(Woodworth et al 1970). Kornfeld (1969) was able to show 
differences in elution on gel filtration between the .diferric and 
apotransferrin; · while Charlwood (1971) demonstrated a 0.7% 
decrease in the Stokes radius of the molecule per iron atom bound. 
It is interesting that the N-terminal domain of transferrin 
contains fewer disulphide bonds ~MacGillivray et al 1982) 
suggesting less conformational stability; Price and Gibson (1972) 
showed that the two sites varied in their susceptibility to 
conformational changes induced by perchlorate. The importance of 
conformation in iron-binding is further attested to by Baldwin 
(1980) who observed that denaturation with detergents caused loss 
of iron from the protein. 
Transferrin may bind none, one (on either binding site) or two 
iron atoms. The currently accepted nomenclature (Figure 2) is as 
follows (Frieden and Alsen 1980): Tf for apotransferrin 
containing no iron; FeNTf for monoferric transferrin with FeIII 
attached to the site closer to the N-terminal (previously 







Figure 2. Diagram illustrating the formation of the species of 
FeIII-transferrin. Tf = apotransferrin; FeN-Tf represents 
transferrin with iron attached to the N-terminal site (formerly 
designated the B site), and TfC-Fe represents transferrin with 
iron attached to the C-terminal binding site (formerly designated 
the A site), and Fe(III)2-Tf represents diferric transferrin. 
After Frieden and Aisen (1980). 
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FeIII bound to the site closer to the C terminus (previously 
designated the A site); Fe 2Tf or FeNTfFec for diferric transferrin 
with FeIII on both sites. 
The metal-free and complexed transferrins differ in their 
solubilities in 40% ethanol, resistance towards proteolysis, 
alkali, thermal and urea denaturations, iodination and treatment 
with disulphide-breaking reagents (Warner 1954; Azari and Feeney 
1958; Glazer and McKenzie 1963). In all cases, the iron-transferrin 
complex is found to be more stable than the apoprotein. Zschocke 
et .al (1972) found 6-7 protected free amino acid groups that were 
less reactive in the iron-complexed than the metal-free protein. 
Although t~ese groups were apparently not involved in the binding 
process, the further fact that modificatiori' of these residues led 
to denaturation of the protein suggests that these residues may be 
involved in determining the tertiary structure vis-a-vis iron 
chelation. Much earlier, Fraenkel-Conrat and Feeney (1950) had 
suggested that metal chelation may not arise from a simple 
interactfon of iron with some group on the protein, but may be 
dependent on a specific configuration assumed by a number of 
residues to form a site of proper geometry for the iron atom. 
Evidence was provided by titration studies (Wistinia et al 1961) 
that a large number of tyrosine residues, including those involved 
in the binding of iron, are hydrogen-bonded, thus contributing to 
both the secondary and tertiary structures. Further supportive 
evidence is provided by Bezkorovainy and Grolich (1971) who showed 
that the tyrosyl residues that bind iron are distributed over a 
relatively large section of the polypeptide chain. In recent years 
the technique of separating transferrin according to its iron 
content by polyacrylamide electrophoresis in the presence of high 
concentrations of urea has been developed (Makey and Seal 1976). 
Urea denatures by affecting the tertiary structure of the protein: 
the hydrophilic outer residues "prefer" the urea environment to 
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that of the hydrophobic inner residues, resulting in unfolding of 
the protein. The urea electrophoretic technique is dependent on 
the greater resistance of the iron-complexed protein to unfolding. 
The two monoferric forms are distinguishable due to the different 
configurations of the two domains. 
Metal-binding also affects the isoelectric behaviour of 
transferrin: the synergistic binding of one iron atom together 
with one bicarbonate molecule results in an increase in negative 
charge, by -1, on the protein. Thus monoferric transferrin will 
have a lower pI than apotransferrin and diferric transferrin will 
be even lower. Thus the three transferrin species - the two 
monoferric forms cannot of course be separate_d - may be . separated 
(Wenn and Williams 1968) at pH's 5.2, 5.6 and 5.9 respectively. 
It has also been shown (Kourilsky and Burtin 1968) that the three 
transferrin species react differently on immunoelectrophoresis in 
agarose, probably due to ~harge differences between them. 
3.2.3. Functional Differences in the Binding Sites. 
The Fletcher-Huehns hypothesis 
There are clearly physical differences between the binding sites, 
as shown by electron paramagnetic resonance studies (Aisen et al 
1969, 1973; Cannon and Chasteen 1975). The two sites also show 
different pH dependencies (Lestas 1976; Princiotta and Zapolski 
1975), with the N-terminal site being more susceptible to proton 
attack. This point is, incidentally, interesting, in view of the 
fewer disulphide bonds contained in this domain, presumably 
leading to a less stable conformational state. Whether the two 
sites are functionally different or not is still a matter of 
controversy. This hypothesis, (Figure 3) originally proposed by 
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Figure 3. Diagrammatic representation of the Fletcher-Huehns 
hypothesis. Regulation of absorption could occur if there is a 
means of controlling amounts of iron transferred from the mucosa 
to the plasma. It is postulated that this could if the ironbinding 
site (the C-terminal site) on transferrin preferentially cleared 
by red cell precursors and placenta is particularly avid for iron 
from the intestinal mucosal cells. After Fletcher and Huehns 
(1968). 
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which labels first, is delivered preferentially to metabolically 
active sites such as maturing erythrocytes, while that from the 
second, subsequently labelled site, is delivered primarily to 
storage sites. Thus the saturation of the binding sites may act as 
a •messenger" to the body or the tissues' requirement for iron. 
This hypothesis was further extended to include the control of 
iron absorption: the amount of iron on plasma ·transferrin's 
binding sites could act as the "messenger iron• of Conrad et al 
(1964), although these authors used the term in the context of 
ferritin. The saturation of transferrin and in particular the 
amount of diferric transferrin present in the p~asma, the fraction 
that delivers iron preferentially to storage sites, is dependent 
on both erythtopoeitic activity and body iron stores, both of 
which control the rate of absorption (see above). Thus the 
saturation of transferrin would determine the amount of iron 
incorporated into developing mucosal cells, as any other storage 
site, and, superimposed on this, would be the effect of the 
binding sites available to pick up absorbed iron. States of iron 
need such as iron deficiency or pregnancy would increase the 
transferrin concentration in the plasma as well as reducing its 
iron saturation, thus less iron would be deposited in newly formed 
cells and more sites would be available for picking up iron, hence 
the observed increase in absorption. It has been found that FeNTf 
. is the major transferrin species in the serum of normal subjects, 
a phenomenon that has been ascribed to the ionic composition of 
the serum (Leibman and Aisen 1979). Dialysis of serum leads to 
the migration of iron to the c-terminal site. Baldwin (1980) was 
able to manipulate the sites by using various salts and 
detergents: the sites could be made kinetically either homo- or 
heterogeneous; this was ascribed to conformational changes. 
A great deal of work has been done on the roles of the two binding 
sites in the delivery of iron to reticulocytes, both in vivo and 
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in vitro, in attempts to confirm or refute the Fletcher-Huehns 
hypothesis. According to the hypothesis, these red cell precursors 
should take up iron preferentially from diferric transferrin. In 
summary, studies using heterologous systems, such as human 
transferrin and rabbit reticulocytes (e.g. Awai et al 1975; Okada 
et al 1978, 19791 · support the hypothesis, 
while those using homologous systems, human-human or rabbit-rabbit 
(e.g.Huebers et al 1981) do not. A recent paper (Van der Heul et 
al 1981), using sophisticated techniques of producing accurately 
labelled monoferric transferrin in a homogeneous human system, 
shows categorically that there is no functional difference between 
the two sites. The mechanism of uptake of transferrin by 
reticulocytes and other cells and the receptors involved have also 
received much attention. That transferrin may actually be taken up 
by reticulocytes was flrst suggested by Jandl et al (1959). 
Later, evidence was provided that transferrin binds to a receptor 
(Baker and Morgan 1969). It has been suggested (Fielding and Speyer 
1974; Workman and Bates 1975) that the iron is removed at this 
stage, while .the transferrin is attached to the receptor on the 
cell surface; how the iron enters and is transported through the 
cell was not postulated. There is however morphological evidence 
(Sullivan et al 1976; Hemmaplardh and Morgan 1977; Karin and Mintz 
1981) that transferrin is actually taken up in an energy-dependent 
vesicular process, releases its iron within the cell and is 
returned to the circulation intact. Details of the steps occurring 
within the cell are not known. 
3.3. Ferritin. 
The iron-storage molecule ferritin was first described by 
Schmiedeberg in 1894 who called it "ferratin". The protein was 
isolated from horse spleen in 1937 by Laufberger who described it 
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as an iron depot and gave it the name of "ferritin". Ferritin is 
found widely throughout the animal kingdom; so-called 
"phytoferritins" have been found in plants and recently a related 
species in fungi (Aisen and Listowsky 1980). This widespread 
distribution is an indication of its early evolution and 
physiological importance. Ferritin is found in most tissues 
especially in iron storage sites such as liver, spleen and bone 
marrow. The related form, haemosiderin, an insoluble complex of 
inorganic iron associated with protein and other substances in 
variable proportions,is thought to be a degradation product of 
ferritin (Richter 1959; Fischbach et al 1971) and will not be 
discussed further. 
Ferritin is a hollow nearly spherical protein, with an internal 
• 0 
radius of ·37A and an external radius of 61A, as measured by X-ray 
and electron microscopic studies (Fischbach and Anderegg 1965). It 
has a molecular weight of 450000 and a sedimentation constant of 
17-18S (Crichton 1973). The iron is deposited within the shell and 
single molecules may accommodate little or no iron to a maximum of 
approximately 4500 atoms per molecule: the fact that the iron is 
encapsulated within means that it has no direct effect on 
electrophoretic mobility, immunological and other properties 
(Harrison 1964) which depend only on the protein shell. Ferritin 
consists of 24 subunits of molecular weight approximately 18500 
daltons each; these are arranged in 4 3 2 symmetry to form a 
spherical molecule (Treffrey et al 1979). These subunits may be 
dissociated by acetic acid at 0°c (Harrison and Gregory 1968) or 
by sodium dodecyl sulphate at 60-80°c (Bryce and Crichton 1971). 
I 
I 
Ferritins from a wide variety of species show very constant amino 
acid compositions: all contain about 40% non-polar residues and a 
nearly constant 13-15 residues per subunit of alanine (Crichton et al 
1973). However, ferritins from different tissues of the same 
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species or individual show significant differences (Arosio et al 
1978). These differences show up on polyacrylamide g~l 
electrophoresis, where a monomer band containing most of the 
ferritin and more slowly moving oligomer bands are found (Harrison 
et al 1974) and on isoelectrofocusing where the protein may focus 
in a series of small peaks (Wagstaff et al 1978). It has been 
suggested that the latter may be due to differences in iron 
content (Ishitani et al 1975), although neuraminidase treatment of 
the sialic acid residues simplifies the isoelectrofocusing 
profiles (Cynkin and Knowlton 1977), suggesting that part of the 
heterogeneity may be due to differences in carbohydrate 
composition. 
It has been suggested that the microheterogeneity of so-called 
"isoferritins" from different tissues of the same individual may 
arise from the presence of two subunits of different primary 
structure (Drysdale et al 1977; Arosio et al 1978): the so-called 
"L" or "light" subunit which predominates in · liver ferritins and 
the "H" or "heavy• subunit, predominating in heart ferritins. 
These two ·subunits may be present in varying proportions ranging 
from the homopolymer L24 tt0 to the other homopolymer L0tt24 • Six 
channels exist through the protein shell into the interior of the 
molecule (Banyard et al 1978); these are believed to be large 
enough to allow the passag~ of small ions or molecules e.g. Fe2+ 
aq., Fe (OH) 2 aq., o2; I03 etc. which can diffuse into the inner 
cavity. Large polymeric FeIII species would not however be able to 
penetrate. The iron core consists of an inorganic iron polymer or 
micelle, predominantly FeO-OH, but also with some 1-1.5% 
phosphate, with the formula (Fe00H) 8 (Fe0:0P03tt 2) and a radius of 
approximately 35A. The structure of the iron core is suggested 
(Towe and Bradley 1967) to consist of FeIII atoms arranged in 
octahedral positions between hexagonally packed oxygen layers. 
This model has received support from electronic absorption spectra 
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and extended X-ray absorption fine structure, EXAFS (Webb and Gray 
1974). 
It has long been known that deposition of iron into ferritin 
requires the metal in the FeII form and that, once deposited, this 
iron exerts a catalytic effect, inducing more and more deposition. 
A number of theories have been proposed to account for the 
deposition of iron into ferritin: firstly, a model based on the 
chemistry of ferric · chelates and the tendency of iron to 
polymerise giving water and soluble micellar cores {Spiro and 
Saltman 1969). The theory (Pape et al 1968) proposed that the 
ferric oxyhydroxide core is first formed with the protein subunits 
subsequently forming a shell around it. This theory has received 
. 
little support,-- particularly in view of the demonstration 
(Niederer 1970) that iron is taken up gradually, as shown by the 
increasing density of ferritin samples over time, demonstrated by 
isopycnic centrifugation of ferritin samples over time. The more 
accepted theory involves the penetration of FeII through the 
channels in the shell, followed by oxidation on the inner surface 
of the protein. It is presumed that some coordination sites are 
first occupied by water, protons are lost and linkage of further 
FeIII occurs through oxo and hydroxy bridges. This is the stage 
where a catalytic effect occurs: it has been observed (Macara et 
al 1972,1973) that iron taken up by ferritin exerts a "catalytic" 
effect, resulting in the deposition of more iron. The polymer 
formed soon becomes too large to escape the shell (Clegg et al 
1980). A modification of this theory involves the presence of 
active sites on the apoferritin shell which catalyse the oxidation 
of FeII (Crichton et al 1977) although other authors have thought 
this unlikely (Macara et al 1972, 1973). 
The kinetics of formation of the iron core are consistent with 
those of crystal growth, following a sigmoidal curve. This has led 
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to the proposal of the •crystal growth model" (Macara et al 1972) 
in which the initial nucleation step is followed by a more rapid 
growth stage, increasing as the surface area available for 
crystallisation increases, which would account for the catalytic 
effect. 
It has long been known that administration of iron leads to an 
increase in the ferritin concentration ~f the tissue concerned. 
It was noted by Granick (1946) for instance, that oral doses of 
iron lead to increased amounts of ferritin present in the duodenal 
mucosa of guinea pigs; he put forward the hypothesis that the iron 
causes an apparent induction of ferritin by stabilising a 
previously unstable precursor (apoferritin). There is evidence 
that iron-rich ferritin is more resistant to eniymic and ly~somal 
(Crichton 1971) degradation than the iron-free form. Fineberg and 
Greenberg (1955) however, showed that iron stimulates de novo 
synthesis of ferritin, with apoferritin as the initial product. 
This was confirmed by Drysdale and Munro (1966) who, using density 
gradient ultracentrifugation, found that the apoferritin fraction 
was more active soon after administration of 14c-glycine. The 
iron-induction of ferritin synthesis has been confirmed in 
numerous tissues, e.g. rat liver (Coleman and Matrone 1969), 
spleen, kidney, duodenum and testis (Yoshino et al 1968). 
Actinomycin-D does not affect the stimulation of ferritin 
synthesis (Drysdale and Munro 1966; Zahringer et al ·1976). Iron 
administration does however increase the amount of ferritin mRNA 
engaged in protein synthesis (Zahringer et al 1975). Pretreatment 
of animals with cordycepin, an inhibitor of polyadenylic acid 
3'-tail formation on addition to mRNA before transport from the 
nucleus to cytoplasm, failed to reduce the increase in ferritin 
mRNA induced by iron administration (Zahringer et al 1976), 
implying a cytoplasmic source for the latter. It was suggested 
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that in the tissues of animals not receiving excess iron, a 
ferritin subunit is attached to the initiation site of ferritin 
mRNA preventing the latter from binding to the ribosomes. The iron 
entering the cell would then shift the equilibrium towards 
assembly of completed ferritin shells, so that the inhibiting 
subunits are mobilised and more mRNA becomes available. 
Ferritin has been demonstrated in the intestinal mucosa (e.g. 
Granick 1946; Smith et al 1968) ·and has been postulated as the 
factor regulating iron absorption: the so-called •mucosal block" 
theory (see above). 
There is thus a vast literature on iron metabolism, of which this 
review has attempted to give only a brief outline, and only in 
relation to the topic under investigation, iron absorption. Much 
of the literature on absorption is itself confusing: there are 
data supporting both active and passive transport as the mechanism 
involved. It would appear from consideration of the available 
evidence that both may have a role to play, perhaps depending on 
the dose of iron presented to the cells. Iron-binding proteins 
have been identified in almost all the cellular fractionation 
studies: consensus of opinion is that these are transferrin, or a 
transferrin-like protein, and ferritin. Other proteins of both 
higher and lower molecular weight have also been found. 
Absorption has been shown to be dependent on protein synthesis, 
suggesting a protein carrier, although there is the possibility 
that this could represent an indirect event not on the actual 
transport pathway. Iron has been found in associaton with the 
endoplasmic reticulum and the mitochondria: the role of these in 
absorption is unknown. 
This study, therefore, is an investigation of the iron absorption 
process, into the possible mechanism involved, and, in particular, 
into the iron-binding proteins of the mucosa. There is little 
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quantitative evidence on the last-named topic and this study will 





Adult (>300g) male Long-Evans rats were used throughout. Animals 
were fed on a standard rat diet (Epol, Johannesburg) containing 
lpg/g of iron as ferrous sulphate. Iron stores were reduced and 
erythropoeisis stimulated by venesection of 20 ml of blood over a 
two week period, or increased by intramuscular injections of 100mg 
iron as iron dextran (Imferon, Fisons Pharmaceuticals) two weeks 
prior to study. Haemoglobin was measured by the 
cyanmethaemoglobin method (International Committee for 
Standardisation in Haematology, 1971), reticulocytes by the method 
of Hillman and Finch (1969) and splenic non-haem storage iron by 
the method of Torrance and Bothwell (1968). 
4.2. Absorption in Vivo from Isolated Loops. 
Rats were anaesthetised with pentobarbital sodium (Sagatal, 
Maybaker, S.A.), the abdomen opened and loops, 5 or 10 cm in 
length, ligated between ligatures in the small intestine. Care was 
taken not to damage the blood supply. 0.3 ml of a radioiron 
solution containing 0.15M NaCl, 50pM (3~Jr~°1ron + 59 Fe (0.75 µCi; 
Amersham International Limited) and 0.4mM ascorbic acid, pH 4.2, 
was injected into the loop and absorption allowed to proceed for 
one half or one hour. Data on the viability of such loops and 
reversibility to normal function after removing ligatures, is 
given in Appendix 1. Blood samples were taken from the tail vein 
at 5 minute intervals and aliquots of these counted for 59Fe 
activity. Thereafter, the loop was removed, washed with 40 ml cold 
saline and counted for 59Fe in a gamma counter (Beckman 
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Instruments). The remaining carcass was counted in a small animal 
whole body counter, both against standards contained in a similar 
volume (see Counting of Radioactivity). 
To determine the effects of increasing iron dose on absorption, 
icon doses of 50pM (3~g), 500pM (30pg) and SmM (300pg) iron as 
ferrous ascorbate were used. 
The kinetics of iron loading by iron-binding components of the 
mucosa were investigated by pulse-chase studies using either "hot" 
or "cold" chaser solutions. The iron solution labelled with 59Fe, 
was incubated in the loop for 5 minutes, followed by either "cold" 
chase of 50uM cold ferrous ascorbate or "hot" chase of 50pM iron+ 
55Fe (lµCi 55Fe; Amersham International Limited) which was left 
for 5 - 30 seconds before removal and washing as above. 
4.3. Cell Isolation. 
Cells from 5 cm segments were removed by one of two techniques: 
firstly by vibration of everted loops (Savin and Cook 1978) on a 
glass rod at 50Hz for 10 minutes; the cells, resuspended to a 
final volume of 1 ml, gave, on average, cell counts of s.sx106 
cells/ml measured in a haemocytometer, and 5.8lt0.90 mg protein as 
determined by the biuret method (n=S). Secondly, the loop was 
opened, the cells gently scraped off the underlying lamina propria 
with a glass slide and resuspended to a final volume of 1 ml. This 
yielded an average count of 12.3x106 cells/ml and 15.5lt4.42mg 
protein (n=20). For both techniques, Trypan Blue exclusion 
confirmed >95% viability. 
4.4. Iron Uptake by Isolated Cells. 
Based on the method of Savin and Cook (1978), the radioiron 
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solution was added to 200 pl of a cell suspension containing 3xl0 3 
cells/pl and incubated at 37°c with shaking. Aliquots were removed 
at 5 minute intervals, pipetted onto a filter (pore size: 0.45p), 
washed with 40 ml cold saline and the activity on the filters 
counted. In control experiments, cells were incubated at 4°C or 
preincubated with 1 mM potassium cyanide or 1 mM sodium arsenate 
for 10 minutes before washing and being added to the 
iron-containing solution. The effects of ethylene 
diamino-tetra-acetic acid (EDTA) on iron uptake were tested 
firstly by vibration of cells into buffer containing 5 mM EDTA, 
followed by washing in two changes of buffer, and secondly, after 
incubation with iron-containing solution, cells were washed with 
saline containing the same concentration of the chelate. To 
· investigate the effect of variations in iron concentration and 
in~ubation time on uptake, three experiments - were performed: 
firstly, the concentration of iron in the uptake 
. ,_.., 




(6 µg) and - 150pM 
(9 pg) iron. Secondly, cells were.incubated with 50 pM iron for 10 
minutes after which the iron concentration was increased to 75 µM 
(4.5 pg) with cold ferrous ascorbate; thirdly, cells were 
incubated with 25 µM (1.5 pg) iron as cold ferrous ascorbate for 
10 minutes, followed by addition of the further 1.5 µg (to 50 µM 
iron) in the form of 59 Fe ferrous ascorbate. 
4.5. Density Gradient Fractionation of Cell Homogenate 
Washed cells were suspended to final volume of 1 ml in 0.15M 
saline containing proteolytic inhibitors (S mM 6-amino caproic 
acid, 20 pM phenylmethylsulphonylfluoride (PMSF) and 100 i.u. 
Trasylol) and homogenised with 30 strokes of a Dounce homogeniser. 
10-50% sucrose density gradients of 17.5 ml in MES buffer were 
used (0.lM 2-(N-morpholino) ethane sulphonic acid (MES); lmM 
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ethyleneglycol-bis (B-amino-ethyl ether) N,N'-tetra-acetic acid 
(EGTA, Sigma), 0.02% NaN 3 , pH 6.5) (Pearse 1975). 0.8 ml cell 
homogenate was applied to each and centrifuged for 16 hours at 
52000g in a swinging bucket rotor (SW 27.1, Beckman L2-65B 
ultracentrifuge). Fractionation was by upward displacement of the 
gradient on a density gradient fractionator (Instrumentation 
Specialties Company, Nebraska). Data on the calibration of the 
gradients is shown in Figure 4. The collected fractions were 
counted for 59Fe and assayed for transferrin and ferritin. 10 mM 
ferrous sulphate was added to cells during homogenisation when 
required. The gradient densities established after centrifugation 
were measured by densitometry and ranged from 1.04 to 1.20 g/ml in 
the first and last of 30 fractions. Mitochondria have reported 
densities of 1.29 g/ml (Beaufray et al 1964) and 1.15-1.20 g/ml 
(Hopkins and Peters 1979). Assay for the marker enzyme creatine 
kinase found on the mitochondrial inner membrane on a Centrifuchem 
System 400 centrifugal analyser (Roche) indicated the presence of 
mitochondria at 1.18 g/ml density (fractions 27-28). 
To determine whether handover of iron occurred between the 
different iron-binding components separated on the density 
gradient, 0.2 ml from one radiolabelled peak was added to the same 
volume from under another, unlabelled, peak, incubated at 37°c for 
1 hour with shaking, the density equilibrated with buffer to a 
final volume of 0.8 ml and applied to the gradient before 
centrifugation as above. 
4.6. Immunoabsorption. 
Antisera produced in rabbits against transferrin and 
ferritin were dialysed overnight at 4°C against 0.05M Tris/HCl, 
pH 7.4, and the IgG separated by DE-52 (Whatman) chromatography. 















Figure 4. Calibration of sucrose density gradients after 
centrifugation. Measurement was determined by direct densitometry 
of each fraction. Each fraction is equal to 0.6ml; the total 
volume of the gradient is approximately 17.5 ml. 
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Sepharose 48 (Pharmacia). The transferrin and ferritin 
antigen-binding capacity was estimated for each column using 
varying concentrations of labelled transferrin and ferritin with 
unconjugated Sepharose 48 as a control. The capacity of the 
anti-transferrin column was 16 µg transferrin/ml and that of the 
anti-ferritin column l.5µg ferritin/ml. Cell homogenates, 
clarified by centrifugation at 1000g for 10 minutes, were 
incubated with 1 ml immunoabsorbent with constant · mixing at room 
temperature for 4 hours and eluted through a further 1 ml of 
immunoabsorbent with 0.15M NaCl. The eluates were fractionated on 
sucrose density gradients and the fractions assayed for 
transferrin and ferritin. 
4.7. Gel Filtration. 
A 100 x 1cm column of Ultrogel AcA-34(LKB) was calibrated with gel 
filtration molecular weight markers (Pharmacia). 0.3 ml 
Triton-treated sample was applied and eluted with MES buffer. 2 ml 
fractions were collected and counted for 59Fe and assayed for 
transferrin and ferritin. 
4.8. SDS-Polyacrylamide Gel Electrophoresis. 
lxl50xl50mm polyacrylamide gels containing 1% sodium dodecyl 
sulphate (SDS) were run at 50V for 16 hours in a Hoechst Model 
SP1000 electrophoresis apparatus. The acrylamide gradient ranged 
from either 5-20% or 6-8%. Gels were stained with Coomassie Blue 
(Laemmli 1970). 
4.9. Metabolic Inhibitors. 
A solution of 5mM cytochalasin-B (Sigma), initially dissolved in 
dimethylsulphoxide (B.D.H.) was incubated in the intestinal loop 
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for 15 minutes (Carter 1967) before washing with 10ml saline and 
injection of the iron- ascorbate solution. To investigate the 
dose-response effects behaviour of the substance, concentrations 
of 100pM, lrnM and 10rnM were used. Incubation of the iron-ascorbate 
solution was allowed to proceed for 5 minutes; in order to test 
the recovery time, incubation timei of 5, 10, 15 and 20 minutes 
were used. Blood samples were taken during this time, and 59 Fe 
activity in 100µ1 aliquots of these counted to determine whether 
absorption was occurring. 
Similarly, 10rnM colchicine (Sigma) was inc~bated in the loop for 2 
hours (Taylor 1965); doses tested were l00pM, lrnM and 10rnM. The 
effects of vincristine (Petersen Ltd., ~outh Afric~) at normal 
dose of 0.lmg/ml (Hemmaplardh et al 1974) and test doses of 
lpg/ml, 10µg/ml and l00pg/ml were also investigated. Incubation 
time in this case was 15 minutes. Similarly, lrnM KCN was 
incubated in the lo6p for 15 minutes. 
4.10. Radioimmunoassay of Transferrin. 
Rat serum transferrin was prepared by the method of Sutton and 
Karp (1968) with the additional step of passage through a lx5 cm 
column of Blue S~pharose (Pharmacia) to remove contaminating 
albumin. Purity was tested by homogeneity on polyacrylamide gel 
electrophoresis. 
The antisera used were either commercially produced rabbit antirat 
transferrin (Cappel Laboratories) or antisera raised in rabbits 
with initial injection of 0.1ml solution containing lpg protein in 
Freund's Complete Adjuvant into the retrocrural lymph node 
followed by weekly intramuscular injections of the same. The 
rabbits were bled after 4 weeks and the presence of antibodies 
tested by immunoelectrophoresis (Graber and Burtin 1964) and 
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precipitation on Ouchterlony plates (Ouchterlony 1962) in 1% agar 
gel with Beckman (Beckman Instruments) buffer. The 
immunoprecipitates were stained with amido black and destained in 
7% acetic acid. Radioautographs (X-Omat, Kodak) were taken to 
determine the position of radiolabelled transferrin, if such was 
used. Iodination was perfomed by the Chloramine-T method of 
Greenwood et al (1963). The optimum concentrations of both 
Chloramine-T and transferrin were established in advance and the 
latter was standardised as 10µg transferrin. The excess· unreacted 
125I was separated from the labelled protein by Sephadex G-25_ 
chromatography using a 25 x l cm column eluted with phosphate 
buffer (5mM NaH 2Po4 ; 0.01M Na 2HP04 , pH 6.8). 
Samples were assayed in duplicate together· with a doubling 
dilution series of 14 standards of purified serum transferrin and 
tubes (4 of each) containing the total amount of radiolabelled 
protein added to each sample, the radiolabel with addition of 
antiserum, to give the uninhibited upper limit of the assay and 
radiolabel with no antibody added, for the non-specific binding. 
All these tubes were incubated in the same manner as the standards 
and samples. Samples were incubated in plastic test tubes (Falcon, 
Oxnard, U.S.A.) in a reaction volume of 400pl; bovine serum 
albumin buffer (0.04M NaH2P04; 0.lSM NaCl; 0.1% NaN3; 0.01M EDTA 
and 0.5% BSA pH 7.4) was used as a carrier. The antibody titre 
was determined so as to give 35% binding of tracer to antiserum in 
the absence of unlabelled antigen. This was established by the 
incubation of serial dilutions of antiserum with constant amounts 
of 125I-transferrin according to the standard assay 
protocol. The optimum titre for the antiserum from rabbit 
number 311 was found to be 1/10000 and that for the 
commercially produced antiserum 1/200000 (Figure 5). 
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Figure 5. Antibody dilution curves of transferrin antiserum 311 
and commercially-produced antiserum {Cappel Laboratories). 15 
doubling dilutions of antisera were incubated with radiolabelled 
transferrin and BSA buffer according to the standard assay 
procedure. The antibody dilution giving approximately 35 % 
precipitation was used in subsequent assays.A, Antiserum 311. 
The starting dilution for this antiserum was 1/100 and the 
antiserum dilution used for subsequent assays was 1/100000; 
B, Commercially-produced antiserum. The starting dilution was 1/100 
and the dilution used in subsequent assays was 1/200000. 
-62 
the bound and free tracer was achieved by addition of second 
antibody system: l00pl of normal rabbit serum followed by 100pl of 
donkey anti-rabbit serum, on the second day. Precipitates were 
washed the following day with 1ml BSA buffer and counted for 125r 
activity. 
Results were calculated by -n adaptation of the Fortran programme 
of Rodbard and Lewald (1970) run on _a Univac 1106 computer. This 
programme fits the standard curve of the assay to a linear 
function from which the values or •potency estimates• of unknowns 
can be calculated. This linearisation of the standard curve is 
performed using the logit-log relationship: 
logit (Y) =a+ b loge (X) 
where: Y is Bl/B0, the ratio of bound counts to counts bound in 
the absence of unlabelled antigen, with both values corrected for 
non-specific binding counts; 
logit (Y) is loge (Y/(1 - Y)); 
Xis the dose of unlabelled antigen; 
and a and bare the intercept and the slope, respectively, of 
the linearised curve. 
The derivation of antiserum affinity data by means of the 
Scatchard plot analysis, the derivation of part of the data 
relevant to proficiency testing and quality control of the assay 
were also performed by the programme. 
To investigate immunological differences between rat transferrins 
from different tissues, 5 duplicate doubling dilutions of purified 
serum transferrin, rat serum, rat mucosa, including whole 
homogenate, as well as Peaks 1 and ,3 from density gradient 
fractionation · were assayed in the presence of proteolytic 
inhibitors (see above), 2% Triton-Xl00 and BSA buffer. The effects 
of other buffers, notably MES and saline, as well as the presence 
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of sucrose from the density gradients, were also investigated. No 
effects of these variables were found. To investigate 
immunological differences between diferric, monoferric and 
apotransferrin, these species were assayed, in 5 duplicate 
doubling dilutions, in BSA buffer without EDTA. 0.02M 
FeIII-nitrilotriacetic acid (FeIII-NTA) was prepared by the method 
of Woodworth (1966). It was calculated that 1ml of FeIII-NTA 
contained 110µg of ir6n. 1mg in 1ml of serum transferrin was 
used. Apotransferrin was prepared by dialysis of transferrin for 
20 hours at 4°c against 4 litres of 0.05M EDTA, 0.lM NaH2Po4 , pH 
5.5, followed by dialysis for 24 hours at 4°c against 4 litres of 
distilled water, followed by dialysis for 24 hours against 4 
changes of 10mM Tris, 150mM NaCl, pH 8.5. FeIII-NTA was added, 
lul at a time, to 1ml of lmg/ml transferrin solution. Optical 
densities 200-500nm were scanned in a Unicam SP1800 Ultraviolet 
Spectrophotometer. Aliquots of each solution after addition were 
retained for parallel line radioimmunoassay. 
The computer programme used to analyse this data was a parallel 
line affinity analysis adaptation of the Rodbard and Lewald (1970) 
programme. 
4.11. Radioimmunoassay of Ferritin. 
Rat liver ferritin was purified by the method of Penders et al 
(1971). Purity was confirmed by homogeneity on polyacrylamide 
gels. 
Antiserum was raised in rabbits in the same manner as for 
transferrin. The presence of antiserum was tested by 
immunoelectrophoresis and precipitation on Ouchterlony plates. 
Sµg ferritin were used for iodination, otherwise the assay and 
computer calculations were performed in exactly the same manner as 
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Figure 6. Antibody dilution curve for ferritin antiserum. The 
method was the same as that used for transferrin antibody 
dilution. The starting dilution for this antiserum was 1/50 and 
the dilution used in subsequent assays, 1/1500. 
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for transferrin. The antibody dilution curve of the ferritin 
antiserum is shown in Figure 6. 
4.12. Protein Concentrations. 
Protein concentrations were determined by the biuret method or 
by the Bio-Rad Protein Estimation Kit (Bio-Rad Laboratories). 
4.13. Counting of Radioactivity. 
125r and 59Fe were counted in a Beckman Gamma 310 system. The 
efficiency for both isotopes was about 75%. The window setting 
used for 2 25I was 50-250 and that for 59Fe, 400-600. Samples were 
counted for l minute or a preset error of 5%. The counter was 
equipped with a teletype and paper tape puncher; the paper tape 
was used for input of data to the computer. 55Fe was counted in a 
Beckman liqiud scintillation system LS233 where the efficiency of 
counting was established at 34%. The window used was 50-125. It is 
thus apparent that 59Fe and 55Fe can be counted simultaneously. An 
efficiency of 68% was calculated for 59Fe on the liquid 
scintillation system. Samples, in 5ml Instagel (Packard) were 
counted for 10 minutes or to a preset error of 5%. The 
cross-counting between the two isotopes was 21.25tl.63% for 59Fe 
in the 55Fe setting and 0% in the reverse situation. 
4.14. Absorption from Iron Polymaltose. 
Iron polymaltose, an iron-carbohydrate complex, molecular weight 
100000, was radiolabelled with 59Fe by the method of Mueller et al 
(1973). It has been shown previously (Jacobs et al 1979) that 
absorpion of iron from this complex is comparable to that from 
iron salts. This was confirmed by comparing absorption from 
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differently labelled salt and polymaltose (see Appendix 2) 
Iron polymaltose, containing 3µg of iron as 59Fe, was administered 
in isolated loops in the same manner as for ferrous ascorbate. 
Data on iron polymaltose, including its handover of iron to 
transferrin, ferritin and iron chelates, is given in Appendix 2. 
4.15. Serum Contamination Qf Mucosal Extracts. 
Following the iodination procedure, rat serum transferrin was 
biologically screened to remove free 125r and damaged molecules by 
injection into a rat and harvesting the serum after 24 hours. 
This whole serum was intravenously injected into test animals. 
Blood samples were taken to follow the protein equilibration and 
distribution (Figure 7). After 4 hours when the slow clearance 
phase, denoting equilibration with the tissues had been reached, 
the rat was sacrificed and cells harvested from a series of 5cm 
intestinal segments, coun~ed for 125r and assayed for transferrin 
by radioimmunoassay. By assuming that equilibration has been 
attained, the amount of transferrin in the mucosa may be expressed 
as equivalent to a volume of serum (the •serum-equivalent 
volume•). As control, 125r-alpha-fetoprotein was used in the same 
manner. 
To determine whether transferrin adhering to the outer surface of 
cells can be removed, cells were digested with 0.25% trypsin in 
Hanks Balanced Salt Solution for 1 hour at 37°c. The action of the 
enzyme was stopped with 200 i.u. Trasylol. The transferrin 
concentration in cells before and after digestion was measured by 
radioimmunoassay. As controls, 50µg pure transferrin or 50µg 
transferrin added to cells from a single segment were digested 
under similar conditions. 
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Figure 7. Biological screening of transferrin. Iodinated 
transferrin was injected intravenously into a rat. After 24 hours 
the rat was bled by cardiac puncture and 1ml of this serum 
injected intravenously into a second rat. Blood samples were taken 
at half-hourly intervali 25 rom the tail vein and 100ul aliquots of these were counted for I activity. 
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4.16. Isoelectrofocusing. 
A preparative isoelectrofocusing column of 220ml volume was filled 
with a 5-50% sucrose (w/v) in water density gradient containing 2% 
ampholytes (Ampholine, Pharmacia), pH range 3.5-9.5. The density 
gradient rested on a cushion of 55% sucrose in lM phosphoric acid, 
and a lM ethanolamine solution was layered on the top of the 
gradient. A small portion of the gradient at the estimated 
density of the sample was removed and the sample inserted. The 
column was run at a constant power of 1000 watts (Hoeffer Model 
PS1200 power supply; Hoeffer Scientific Instruments, San 
Francisco), at 4°c for 20 hours. The column was eluted under 
gravity; 2ml fractions collected and their pH, 59Fe activity and 
transferrin and ferritin concentrations measured. 
4.17. Purification of Mucosal Transferrin. 
The small intestines from rats were removed, washed with 0.15M 
NaCl and 5mM PMSF, pH 7.4 and quick frozen in liquid nitrogen. 
Intestines were homogenised in a Waring Blender without thawing 
and extracted with approximately 21 of the above buffer. The first 
extract was centrifuged at 13000rpm (26000g) for 2 hours (JA-20 
refrigerated centrifuge; Beckman Instruments) and the precipitate 
treated with 1% Triton-Xl00. The second extrac~ ~ ~ obtained from 
washing the precipitate prior to Triton extraction, was spun at 
~3000g for 2 hours. Rivanol (6,9 diamino-2-ethoxyacridine lactate; 
Sigma) was added to the supernatants and Triton-extracted 
precipitate to a final concentation of 0.31% (w/v), with constant 
stirring at 4°c. After standing for 2 hours, the solution was 
filtered through Whatman No 1 filter paper and recentrifuged. The 
precipitate was discarded. The supernatant was treated with 
hydrolysed starch and washed in a sintered glass funnel to remove 
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the rivanol. Any excess rivanol was removed by passage through 
Sephadex G25 (Pharmacia). To the salmon-pink eluate was added 
33g/100ml of ammonium sulphate, allowed to stand overnight then 
centrifuged at 26000g for 2 hours. To the supernatant a further 
11g/100ml ammonium sulphate was added and the precipitate 
collected. The precipitate was washed twice with 44% ammonium 
sulphate. The transferrin in the final solution was stabilised by 
addition of 0.2mM FeC1 3 , together with 0.SmM NaHC03 and 0.SmM 
sodium citrate. 
The transferrin-enriched extracts were further purified by gel 
filtration on Biogel Pl00 (Bio-Rad Laboratories) column (100xlcm) 
eluted with SmM Tris pH 7.4; column isoelectricfocusing, as 
described above, and ion-exchange chromatography on DE-52 
(Whatman) resin eluted with a linear gradient of 0-100mM NaCl in 
SmM Tris, pH 8.0 buffer. The transferrin-containing fractions were 
concentrated in polyethylene glycol and dialysed against the 
starting buffer prior to application to the ion-exchanger. 
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5. RESULTS. 
5.1. Absorption in Vivo from Isolated Loops. 
washed loops from all regions of the small intestine showed almost 
identical uptake of iron- at the 3pg dose (21.06+1.68%; n=22) for 
10cm loops. Absorption, whether measured by the appearance of 
radioiron in venous blood or in the carcass, showed a steep 
. I ""'4.. 
gradient over the upper 10cm of the intestine: at the 50µM (3µg) 
dose of iron carcass uptake ranged from 27.40±3.29% (0.822ug) in 
the duodenum to 0. 48±0 .18% (0. 014ug) in the ileum· (Figure 8 and 
Table 4). In iron deficient animals, duodenal absorption 
increased to 45.30±13.19% (l.359µg, n=l0) and in iron loaded 
2.. 'l. 
animals, decreased to ~±0.89% (0.066µg, n=l0) (Table 4). 
Similarly, when the amount of iron presented to the lumen 
increased, percentage absorption decreased, but the absolute 
amount of iron transferred to the carcass rose: 0.82±0.20µg 
i .....L 
(27.4%) iron for a 50µM (3µg) dose of iron, n=l0; 9. 75µg 
(32.5%)for a 500J,JM(830pg) dose of iron, n=5; and 61.35pg (20.4%) 
for a 5mM (300µg) dose of iron, n=3. Exposure of the gut segment 
to iron for longer periods of time did not result in significantly 
increased absorption: absorption of 31.59±2.57% (0.948µg; · n=2) 
was found after 4 hours for a duodenal segment, and l.03t0.25% 
(0.03lµg, n=3) for an ileal segment. Based on the amount of iron 
consumed by each rat in a 24 hour period, all subsequent studies 
, .....t. were carried out in the physiological dose range of 50pM (3yg) of 
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Figure 8. Percentage uptake of iron (3~g, 50µM dose) by washed 
loops (• •> and carcass (A----.) from isolated 10cm intestinal 
loops at different distances _ from the pylorus. 
-72 
Table 4. Carcass absorption of 50pM (3pg) dose of iron by normal, 
iron deficient and iron loaded rats, showing the haematological 
measurements of haemoglobin (column 3), reticulocyte count (column 
4) and splenic non-haem storage iron (column 5), expressed as pg 
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Figure 9. Uptake of iron by isolated duodenal mucosal cells in 
vitro. A dose of 3~g (50uM) iron was used in all cases except for 
(•··· • ·•) in which 9pg (150uM) was used. 
Cells were preincubated with lmM KCN for 10 minutes before washing 
and incubation wih ferrous ascorbate (•-- ---&) ; cells were 
incubated at 37°c (• •) except for (• •) in which the 
temperature was 4°c. 
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5.2. Iron Uptake by Isolated Cells. 
There was an instantaneous uptake of approximately 0.3pg (10%) 
iron in all cases in the 3pg dose range (Figure 9)~ It is 
possible that this may represent non-specific binding to 
basolateral and plasma cell membranes. The isolated cells in 
suspension initially took up iron rapidly but ceased absorbing 
after 30 minutes. That this uptake represented specific binding 
to or uptake into the cell was shown by the inability to remove 
any radiolabel by washing with lmM EDTA. Furthermore, the control 
experiments of applying the radioiron solution alone, without the 
presence of cells, to the filters, followed by washing, did not 
result in adherence of iron to the filters. 
Uptake beyond the 10% point was inhibited at 4°c and partially by 
prior exposure of the cells to cyanide and arsenate (Figure 9). 
If the poisons were added to the incubation medium, uptake of iron 
ceased. Very similar res~lts were obtained by either 
preincubation with or addition of the iron chelator EDTA. 
Increased concentrations of iron (100 and 150µM) in the incubation 
medium resulted in increased uptake of iron in linear fashion 
(Figure 9). Similarly, addition of iron to cells during 
incubation resulted in increased uptake of the metal. Evidence 
that uptake in vitro by isolated cellswas not an artefact was 
provided by the fact that, on fractionation of the cells, uptake 
of iron by mucosal ferritin was observed to have occurred. This 
indicates that uptake into cells was occurring (see below) and 
that the uptake observed was not a non~physiological artefact. 
5.3. Fractionation of Cell Homogenates. 
Three iron-containing peaks were found (Figure 10): 
1. at density l.050-l.068g/ml a peak was present equally 
throughout the small intestine; 
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2. at density l.080-l.110g/ml there was a peak maximal in the 
duodenum, diminishing in size in the jejunum and absent in the 
distal ileum; this peak was less prominent in in vitro labelled 
cells; 
3. at density _l.155-l.180g/ml there was a peak present throughout 
the intestine. 
Recentrifugation of fractions from peaks 1 and 2 indicated that 
they retain their position; peak 3 did likewise except on addition 
of Triton X-100, when the activity moved quantitatively to the 
peak 1 position. Mixtures of fractions under the various peaks 
indicated that peak 1 hancls over iron to peak 2, but not to peak 
3, peak 2 appeared to hand over a small amount of label to peak 1, 
but again none to peak 3, while the latter was capable of yielding 
small quantities of iron to both peaks 1 and 2 (Figure 11). 
Addition of 10 mM cold ferrous ascorbate to the homogenate did not 
affect the positions of peaks land 3, but shifted the 
radiolabelled peak 2 at density l.080-l.110g/ml to density of 
approximately l.095-l.110g/ml without displacing the radiolabel 
(Figure 12). The ferritin antigen shifted together with the 
radiolabel. 
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Time studies, using varying lengths of exposure time (30 seconds 
to 1 hour) of the gut to the radioiron solution, showed maximal 
activity retained by peaks 1 and 2 throughout the time periods 
studied; the activity of peak 2, however, increased over time 
(Figure 13). 
Pulse/chase experiments using differently labelled radioiron 
solutions, gave no conclusive results. No high-flux component was 
identified. 
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Figure 10. Density gradient fractionation of mucosal cell 
homogenates from A, duodenum; B, proximal jejunum, 15cm from the 
pylorus; C, jejunum 15cm from the pylorus; and D, ileum. 
The sucrose density gradient was determined by direct densitometry 
on each fraction (- - - - ) • Similar gradients were used in all the 





































Figure 11. Density gradient re-centrifugation of density gradient 
peaks. Both in vivo-labelled and unlabelled mucosa! cells were 
fractionated on 10-50% sucrose gradients; fractions from under the 
peaks were mixed, as shown in the graphs, incubated at 37°c for 30 
minutes and recentrifuged on 10-50% gradients. 
A, Peak 1 plus: Peak 1 only (•·····•); Peak 1, labelled and 
unlabelled Peak 2 (• • ) ; Peak 1, labelled and unlabelled Peak 3 
( ... -...:.. _ ... ). 
B, Peak 2 plus: Peak 2 only (•····•); Peak 2, labelled a~d 
unlabelled Peak 1 (• •); Peak 2, labelled, and unlabelled 
Peak 3 (•- - - •) • 
C, Peak 3 plus: Peak 3 only (•····+); Peak 3, labelled and 
unlabelled Peak 1 (• •); Peak 3, labelled and unlabelled Peak 2 
(•---•). The density gradients are the same as in Figure 10. 
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5 
10 20 30 
Fractions 
Figure 12. Density gradient fractionation of S9Fe loaded duodenal 
cells homogenised in saline (•····a> and homogenised with 10mM 
ferrous ascorbate <---•>• 











Figure 13. Labelling of mucosal components with 59 Fe as a 
function of time. Radiolabelled ferrous ascorbate (3pg or 50pM 
iron) was. incubated in isolated loops for 2 (• •), 10 <•· •. ·•> 
and 120 (+-- ... ) seconds. The gradient is the same as in Figure 10. 
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5.4. Identification of Iron-binding Fractions. 
5.4.1. Rats on a Normal Iron Diet. 
Transferrin was found in peaks land 3 (Figure 14). The 
transferrin content of peak 3 was 9.9lt2.01% (n = 6) that of peak 
l in the duodenum while in the ileum the transferrin content of 
peak 3 in relation to peak l was 2.88 ± 0.69% (n = 3) (Table 6). 
This difference is significant (p < 0.05). Transferrin levels in 
duodenum and ileum were very similar: 4.25tl.16pg transferrin/mg 
protein (n = 19) in the duodenum and 4.32±0.09µg transferrin/mg 
protein (n = 19) in the ileum (Table 5). The specific activity of 
transferrin was not ·able to be calculated due to the presence of 
other iron-binding components in the fractions (see Gel Filtration 
and Immunoabsorption). 
Ferritin was piesent predominantly in peak 2, with a density 
between 1.080 and l.ll0g/ml. Small amounts were present in peak l 
(density l.050-l.070g/ml) and in the high density region (density 
1.150-1.170 g/ml). Ferritin levels, expressed in pg ferritin per 
mg total protein, were greater in the iron-absorbing areas: 
0.22±0.08 in the duodenum (n = 19) and 0.08±0.02 in the ileum 
(n=l9) (Table 6). Most of the ferritin in the latter case is 
present in the low density, iron depleted forms (Figure 14) • . The 
specific activity of ferritin 
cpm per µg ferritin. 
was calculated as 56500 59Fe 
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Figure 14. Density gradient fractionation of normal iron load 
mucosal homogenate. 
A, Duodenum; 
B, Ileum. · 
Counts per minute 59Fe (•····•), transferrin (A---&) and ferritin 
(e----e). The density gradients are the same as in Figure 10. 
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Table 5. The transferrin and ferritin content of the mucosa. The 
total protein concentration of each 5cm duodenal segment is shown 
in column 2; transferrin and ferritin values in columns 3 and 5 
are expressed as µg/mg total protein in columns 4 and 6 
respectively. Only the latter values are given for the ileal 
segments (columns 7 and 8); the mean total protein for the 19 
segments was found to be 12.58t3.37mg, which is not significantly 











































































































































































Mean 15.43 55.32 4.25 3.39 0.22 4.32 0.08 
---------------------------------------------------------------
-84 
Table 6. The transferrin content of density gradient Peak 3 in 
relation to Peak 1. The total transferrin protein is not 
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Figure 15. Density gradient fractionation of venesected (iron 
deficient) mucosa! homogenate. 
A, Duodenum; 
B, Ileum. 
Counts per minute 59Fe <•····II), transferrin (~---.) and ferritin 
(• e). The density gradients are the same as in Figure 10. 
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Table 7. Transferrin and ferritin in the duodenum and ileum of 
iron deficient rats. The values are expressed as pg/mg total 
protein. Total protein values were non-significantly different 





























Table 8. The transferrin content of Peak 3 in relation to Peak 1 






































5.4.2. The Effects of Iron Deficiency. 
The venesection programme alters the need for iron absorption both 
by reducing body iron stores and stimulating erythropoeisis (Table 
4). In iron deficient animals, carcass absorption was increased 
from 27.4t3.29% in the normal animal to 45.3±13.19% (n=l0) from a 
10 cm duodenal segment. 
Considering the iron-binding profiles, peaks 1 and 3 were 
increased and peak 2 was reduced in mucosal cell homogenates of 
the iron-deficient animals · (Figure 15) compared to normal (Figure 14). 
Transferrin levels were increased to 9.66±1.22µ9 
transferrin/mg protein in the duodenum and 8.65±1.09pg 
transferrin/mg ' protein in the ileum (n = 4) (Table 7). Ferritin 
levels decreased in iron deficiency to 0.031±0.0lpg ferritin/mg 
protein in the duodenum and 0.019 ± 0.005 pg ferritin/mg protein 
in the ileum (n · = 3) (Table 7). The transferrin content of peak 3 
in relation to peak 1 was also increased to 23.11 ± 1.35% (n = 3) 
in the duodenum and ,9.50 ± 2.22% (n = 3) in the ileum (Table 
8).The specific activity of ferritin, however, was found to 
increase: 84900 59Fe cpm/µg ferritin. 
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Density gradient fractionation of iron-loaded mucosal 
A, Duodenum; 
B, Ileum. 
Counts per minute 
ferr i tin (• •). 
Figure 10. 
59Fe (•····•), transferrin (A.---...) and 
The density gradients are the same as in 
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Table 9. Transferrin and ferritin in the duodenum and ileum of 
iron loaded rats. The values are expressed as µg/mg total protein. 
Total protein values were non-significantly different from those 













































Table 10. The transferrin content of Peak 3 in relation to Peak 1 





































5.4.3. The Effects of Iron Loading. 
In iron-loaded animals carcass absorption was decreased to 
2.20t0.80% (n = 10) from duodenal segments. Transferrin levels 
were found to be similar to those in the normal animal: 3.86±0.74 
µg/mg total protein (n =4) in the duodenum and 3.51±1.02 µg 
transferrin/mg protein in the ileum (Figure 16 and Table 9). 
transferrin content of Peak 3 was 4.42±0.51% (n = 3) ~hat of peak 
l in the duodenum and 0.80±0.25% (n = 3) in the ileum (Table 10). 
Ferritin levels were increased tp 3.98±2.59 µg ferritin/mg protein 
(n = 7) in the duodenum and 0.33t0.09 µg ferritin/mg protein in 
the ileum (n = 3) (Table 9). The specific activity of ferritin was 
however reduced to 7016 59re cpm/ug · ferritin. 
-93 
5.5. Gel Filtration. 
The membrane-free homogenate yielded 3 peaks (Figure 17). The 
first peak had a molecular weight of approximately 400000 daltons, 
ran in the position of ferritin on polyacrylamide gel 
electrophoresis and was confirmed as this protein by 
radioimmunoassay and immunoabsorption. The second peak had a 
molecular weight of approximately _90000 daltons, ran in the 
position of transferrin on polyacrylamide gel electrophoresis and 
its identity was similarly confirmed by radioimmunoassay and 
immunoabsorption. A third, low molecular weight peak, · less than 
10000 dalto~s molecular weight, did not stain . for protein on 
polyacrylamide gel electrophoresis and did not react in 
radioimmunoassay or immunoabsorption against either transferrin or 
ferritin antiserum. Gel filtration of density gradient peak 1 
showed a transferrin peak and a large low molecular weight peak. 
Peak 2 yielded a ferritin peak and a smaller low molecular weight 
peak. Gel filtration of the Triton-treated peak 3 (not shown) 
yielded ferritin, transferrin and low molecular weight/free iron. 
5.6. Immunoabsorption. 
Transferrin-specific immunoabsorption of the membrane-free 
homogenate removed 56.84±7.28% of peak l (n = 4). 
Ferritin-specific immunoabsorption removed 89.25±0.21% of peak 2 
(n = 4). The results were confirmed by radioimmunoassay (Figure 18). 
5.7. Metabolic Inhibitors. 
The microtubular poisons colchicine and vincristine abolished the 
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Figure 17. Gel filtration of the membrane-free mucosal 
homogenate. 
A, Gel filtration of density gradient Peak 2; 
B, Gel filtration of density gradient Peak l; 
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C, Gel filtration of the membrane-free homogenate. 




































































Figure 18. Density gradient fractionation of eluates after 
ferritin and transferrin-specific immunoabsorption. 
A, Starting material; 
B, Anti-transferrin immunoabsorbent and 
C,Anti-ferritin ~~munoabsorbent. 
Counts per minute Fe <•····•, transferrin (~---~) and ferritin 
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Figure 19. Density gradient fractionation of cells from mucosa 
pretreated with 10mM colchicine for 2 hours <•··• .. ); SmM 
cytochalasin-B for 15 minutes <• •) and control (A.- _ _.). The 
density gradient is the same as in Figure 10. 
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Table 11. The transferrin content of Peak 3 in relation to Peak 1 
in cells treated with metabolic inhibitors. 




























a microfilament poison, did likewise, although in this case the 
effect was reversible. The uptake of iron by Peak 2 was also 
abolished (Figure 19) while the transferrin content of Peak 3 was 
significantly reduced to l.49t0.74% of Peak 1 (n=5) in the 
duodenum (p<0.0l) (Table 11). Dose and time-response curves for the 
three substances are shown in Figures 20,21 and 22. Removal of 
cytochalasin-B led to a progressive increase in iron absorbed and 
incorporated into ferritin (Figure 23). 
The respiratory poison cyanide, ~educedJbut did not abolish either 
carcass uptake or uptake into ferritin (Figure 24). 
5.8. Absorption from Iron Polymaltose. 
Absorption of iron from the macromolecular iron source, iron 
polymaltose, an iron-carbohydrate complex of molecular 
weight 100000 daltons, measured as radioiron 
incorporation into circulating haemoglobin of red cells 
two weeks after administration of iron salt and iron polymaltose 
labelled with different isotopes is non-significantly different 
ferrous ascorbate · 
from that of (p>0.05) for normal, iron. deficient and iron 
loaded rats (Appendix 2). However, fractionation of the mucosa 
after exposure to . the iron polymaltose complex showed minimal 
incorporation of iron into Peak l for normal, iron deficient and 
iron loaded animals (Figure 25). It can be seen from the gel 
filtration studies on Peak l, after exposure of the mucosa to 
ferrous ascorbate, that the low molecular weight component of Peak 1 
comprises approximately 1.5 times the activity of the 
transferrin fraction; exclusion of the low mol~ular weight moiety 
A 
from the total activity of the peak, thus nevertheless results in 
a high-specific activity of the transferrin fraction. Assuming no 
contribution of low molecular weight moiety to the Peak 1 activity 
in iron-polymaltose-treated cells, the specific activity of 
3 












Figure 20. Density gradient fractionation of cells from mucosa 
pretreated with 100JJM <•· .... ) , lmM (• e) and 10mM ( ~- --l.) 
colchicine. 
The colchicine was incubated in the loop for 2 hours, before 
washing and injection of the radiolabelled ferrous ascorbate, 

















Figure 21. Density gradient fractionation of cell homogenates 
pretreated with vincristine. 
A, Cells were pretreated with 0.0025mg/ml (•····•), 0.005mg/ml 
(•---•} and 0.0lmg/ml (• •) vincristine before washing the loop and 
injection of the radiolabelled ferrous ascorbate solution. 
B, The mucosa was pretreated with 0.lmg/ml vincristine for 10 minutes 
(•··· .. ) and 30 minutes (• •) before washing and injection of 
the radiolabelled ferrous ascorbate solution. Density gradients 
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Figure 22. Density gradient fractionation of cell homogenates 
· pretreated with cytochalasin-B. 
A, Mucosa was pretreated with 100µM <•····-a), lmM {•---_.) and 
10mM {• e) cytochalasin. The radiolabelled ferrous ascorbate was 
allowed to incubate for 5 minutes. 
B, Mucosa was pretreated with SmM cytochalasin-B for 5 minutes <•··· ... ) , 10 minutes <•-- --.) and 20 minutes {• •) before 
washing and injection . of the radiolabelled ferrous ascorbate 














Figure 23. Density gradient fractionation of cell homogenates 
after incubation with 5mM cytochalasin-B for 15 minutes, washing 
the mucosa, injection of the radiolabelled ferrous ascorbate 
solution which was allowed to incubate for 10 minutes <•----&), 15 
minutes (• •) and 20 minutes <•····•). Density gradients are 
the samg as in Figure 10. 
Inset, 9Fe activity in 100pl aliquots of blood as a function of 
time after removal of the cytochalasin and injection of the 
radiolabelled ferrous ascorbate. 
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Figure 24. Density gradient fractionation of cells pretreated 
with SmM KCN <•---~) for 10 minutes before washing and injection 
of the radiolabelled ferrous ascorbate solution, and control 
(• e). Density gradients are the same as in Figure 10. 
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Figure 25. Density gradient fractionation of mucosal cells 
incubated with iron polymal tose solution, containin_g 3.)19 of iron. 
A, Mucosal homogenate from normal iron load animal; 
B, homogenate from a venesacted ( iron deficient) animal; and 
c, mucosal homogen~~e from iron loaded animal. 
Counts per minute Fe <•···· .. ) and transferrin (•----,a.). 
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It would thus appear that transferrin in the mucosa of 
polymaltose-treated cells is binding only small amounts of iron. 
Little is known of the mechanism of absorption of iron from the 
polymaltose complex, and while it is possible that the iron from 
this source is traversing the cell by a different absorptive 
pathway to that from ferrous ascorbate, it is possible that the 
absence of free or low molecular weight- complexed iron has 
resulted in the absence of iron uptake by transferrin. 
Trary;ferrin does not accept iron from the polymaltose complex (see 
Appendix 2). The possibility therefore remains that iron binding 
by transferrin, as shown by other experiments, in the mucosa is an 
artefact. 
5.9. Serum •contamination• of Mucosal Extracts. 
Using ~he method of intravenous injection of biologically screened 
proteins, the mean contaminating serum volume per 5cm segment, as 
estimated by the 125I-transferrin method, in 12 segments in twd 
rats, was found to be 8.64tl.4lul (8.73±1.07µ1 in rat 1 and 
8.56tl.47pl in rat 2). The 125I alpha-fetoprotein method yielded 
a mean contaminating serum volume of 9.68±2.04µ1 per 5cm segment 
(no significant difference; p>0.05). Iodinated 
biologically-screened serum added to cells from a 5cm segment in 
vitro yielded a contaminating volume of 7.99±2.13pl 
(no significant difference, p>0.05). 
Serum transferrin levels ranged from l.04-2.10mg/ml with a mean of 
l.56mg/ml (n=lS). Using the mean volume of l.56mg/ml, a 
contaminating serum volume of 8.64µ1 would imply that 13.48µg of 
transferrin would be accounted for as serum contaminant. The 
mucosal cell homogenates contained, on average, 55.4tl2.2µg of 
transferrin/5cm segment (n=39), ranging from 28.7 to 74.lµg of 
transferrin/Scm segment. Since this is well in excess of the 
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estimated serum contaminant, it is apparent that an intrinsic 
mucosa! cell transferrin is present. The contaminating serum 
volume is a calculated parameter, and does not preclude the 
possibility that serum transferrin can become intrinsic to the 
mucosa! cell during the course of the experiment. 
5.10. Trypsin Digestion of Mucosa! Cells. 
Whole cells digested with trypsin showed a small reduction in 
transferrin content measured by radioimmunoassay {Table 12), 
equivalent to a mean contaminating serum volume of 6.55±1.70pl. 
Transferrin itself was undetectable by radioimmunoassay after 
trypsin digestion and there was only a slight retention of 
additional transferrin after digestion of cells to which 
transferrin had been added in vitro. 
5.11. Immunological Comparison of Transferrins. 
The transferrin radioimmunoassay, using labelled serum 
transferrin, was standardised with rat serum transferrin and 
potency estimates were obtained from five serial dilutions of serum 
and mucosa! homogenates. Using the parallel line method of Rodbard 
and Lewald (1973), the transferrin in serum was shown to have an 
identical slope to purified serum transferrin, but there was a 
highly significant difference {p<0.001) in the slopes of serum 
and mucosa! transferrin {Figure 26- and Table 13). Mixtures of 
serum and muco~al extracts yielded an intermediate slope 
predictable for non-interacting components. Constant conditions 
for both samples were maintained in terms of proteolytic 
inhibitors, Triton X-100 and buffer used. As a control, 
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Table 12. Trypsin digestion of mucosa! cells. Whole mucosa! cells 
were digested with 0.25% trypsin for 1 hour at 37°c and aliquots 
were homogenised and assayed for transferrin (column 2). Aliquots 
retained before digestion were also homogenised and assayed 
(column 1). The differences between these values (column 3) is 
the trypsin-accessible transferrin. This is also expressed as a 
serum equivalent volume (column 4) using a mean serum transferrin 
concentration of l.50mg/ml. As controls, approximately 50ug 
transferrin was also digested under the same conditions. The 
added transferr~n is completely accessible to trypsin. 
Cells alone 





Cells plus 107.39 
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Figure 26. Parallel line assays of serial dilutions of rat serum 
(0----0); duodenal cell homogenate (• e); ileal cell homogenate 
(a a); and mixture of serum and duodenal cell homogenate 
(A ~). The F test for homogeneity of variance and the 
Student's t test showed a significant difference (p<0.001) in the 
slopes of serum and intestinal transferrins (method of Rodbard and 
Lewald (1970). The transferrin is in arbitrary units. The 
ordinate is logit Y (ln Y/1-Y) where Y is bound count/unihhibited 
count rate. 
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Table 13. Immunological comparison of serum and mucosa. The 
slopes shown are the result of 5 duplicate doubling dilutions, 
calculated by the parallel line adaptation of the Rodbard and 
Lewald (1970) programme. Serum, duodenal and ileal samples were 
obtained from each rat. The "mix• (column 5) is a 1:1 mixture of 
serum and duodenal mucosa . in appropriate dilutions. 
Rat Serum Duodenum Ileum Mix 
-----------------------------------------------------------
l -0.8168 -1.2575 -1. 8410 -1.1189 
2 -0.8290 -1.4015 -1.3256 -1.1454 
3 -0.8586 -1.5287 -1.7198 -1.1754 
4 -0.8726 -1.2740 -1.3053 -1.1889 
5 -0.8126 -1. 5888 -1.4633 -1.2449 
6 -0.9172 -1.3759 -1.9367 -1. 2253 
7 -0.9446 -1.4808 -1.3963 -1.2424 
8 -0.9838 -1.5872 -1.8070 -1.2754 
9 -0.9746 -1.3362 -1.3790 -1.2931 
10 -0.9357 -1.6741 -1.5357 -1.3201 
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transferrin protein was assayed in the presence and absence of the 
above conditions and no difference was found. No difference was 
found between the transferrins of duodenal and ileal mucosal 
extracts nor between transferrin from Peaks 1 and 3 (Table 14). 
These differences between serum and mucosal transferrin would be 
greater if part of the mucosal transferrin were not due to serum 
contamination. 
When increasing amounts of iron, as FeIII-NTA, were added to serum 
transferrin, and ali~uots after each addition analysed by the 
parallel line assay, no significant difference (p>0.05) was found 
between any of the samples (Table 15). Iron-binding was monitored 
by changes in the absorption at 465nm. Furthermore, there was no 
significant difference (p>0.05) in the affinity slopes of 
antiserum for sera obtained from normal, iron-deficient and 
iron-loaded animals. 
5.12. Isoelectrofocusing. 
Column isoelectrofocusing, pH range 3.5-9.5, of density gradient 
Peak 1 (Figure 27) yielded three transferrin fractions, as 
determined by optical density, polyacrylamide gel electrophoresis 
and radioimmunoassay, at pH's 5.2, 5.5 and 5.6; a small peak at pH 
4.98-5.00, confirmed as ferritin by optical density, 
polyacrylamide gel electrophoresis and radioimmunoassay, and a 
large free iron or low molecular weight peak at pH 1-3.5, which 
does not correspond to an OD 280 peak nor stain for protein on 
polyacrylamide gel electrophoresis, and would thus appear to 
correspond to the low molecular weight compound observed in gel 
filtration studies. Separation of transferrin according to its 
iron content -- increasing negative charge is associated with the 
binding of further iron and bicarbonate atoms is well described 
(Wenn and Williams 1968). A similar pattern was obtained on 
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Table 14. Immunological comparison of density gradient Peaks 1 
and 3. Serum samples were obtaineda~~the same rats as the 
mucosal samples. The slopes shown were derived from 5 
duplicate doubling dilutions of each sample and calculated by an 
adaptation of the Rodbard and Lewald (1970) programme. 
Rat Serum Peak 1 Peak · 3 
1 -0.7214 -1.0080 -1.0724 
2 -0.7504 -1.1052 -0.9164 
3 -0.7467 -1. 0184 -1.1156 
4 -0.8218 -1.4637 -1.5120 
5 -0.8582 -1.8255 -1.6592 
6 -0.9151 -1.4763 -1.6756 
7 -0.8179 -1.5200 -1.8242 
----------------------------------------------------
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Table 15. Immunological comparison of normal, iron deficient and 
iron loaded sera, and the effect of addition of iron to serum 
transferrin in vitro. Iron deficient serum was obtained from iron 
deficient rats (see Table 4) and iron loaded serum from iron 
loaded rats (Table 4). 
Normal Serum Iron deficient Iron loaded Tf+ Iron 
serum serum 
-0.8856 -0.7519 -0.8790 ApoTf -1.0342 
-0.9937 -0.8210 -0.8961 lµl FeNTA -0.9413 
-0.8790 2).11 FeNTA -1.1400 
3µ1 FeNTA -0.9377 
5µ1 FeNTA -0.9605 
10µ1 FeNTA -0.9116 







J: .£ a. 
if 









0) 4-:::i. 0) 
C 







Figure 27. Column isoelectrofocusing of density grad~9nt Peak 1. The pH gradient used was 3.5-9.S. Counts per minute Fe 
<•····•>; pH (<>---¢); transferrin (•---•> and ferritin (• e). 
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isoelectrofocusing of Peak 3: in this case, the transferrin 
content of the sample was lower and only two antigen peaks were 
obtained, corresponding to diferric and rnonoferric transferrin 
(Figure 28). A large ferritin peak was found at pH 4.98 and, 
similar to the Peak 1 profiles, a low molecular weight/free iron 
peak was observed at pH 1-3.5. Isoelectrofocusing of 
SSFe-labelled rat serum together with 59Fe-labelled mucosal 
homogenate, yielded an identical S9Fe and 55Fe distribution in the 
transferrin fractions (Figure 29). 
5.13. Mucosal Tra~sferrin. 
Mucosal transferrin preparation, analysed by the Rodbard and 
Lewald (1973) parallel line method, showed no significant 
difference to previously assayed mucosal homogenates (p>0.05). 
The difference in immunological reactivity between it and serum 
was, however, highly significant (p<0.001). 
5.13.1. Ion Exchange Chromatogiaphy. 
The eluted fractions from the DE-52 ion-exchanger, when analysed 
by optical density at 280nm and radioimmunoassay, showed two major 
transferrin peaks (Figure 30). When these fractions were 
electrophoresed on 6-8% polyacrylamide gels it was found that 
these peaks corresponded to transferrins of different 
electrophoretic mobility (Figure 31). The faster-moving of the 
two bands corresponded to serum transferrin; electrophoresis of 
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Figure 28. Column isoelectrofocusing of density grad!9nt Peak 3. The pH gradient used was 3.5-9.5. Counts per minute Fe <•··--.. ); pH (<>----0); transferrin (4---&) and ferritin (• e). 
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Figure 29. Column isoelectrofocusin~
5
of serum and mucosa. The 
~grum transferrin was labelled with Fe and the mucosal wi~g 
Fe. The pH gradient used wg§ 3.5-9.5. Counts per minute Fe (•. •>; counts per minute Fe (•·· • ·•); pH (~) and 
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Figure 30. DE-52 chromatography of mucosal transferrin. 
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Figure 31. 6•8% sodium dodecyl sulphate polyacrylamide gel 
electrophoresis of fractions from DE-52 ion~exchanger. 
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The two outer lanes contain the starting material, and show tha 
presence of the two forms of mucosal transfeirin (marked with 
arrow), with the DE-52 fractions in between, in which the 
separation of the two transferrins can be seen. The material is 
contaminated primarily with albumin (MW 67000) and another 
unidentified component of lower molecular weight. 
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It is known (Peterson 1970) that OE-52 and other OEAE-cellulose 
media fractionate according to molecular size as well as charge, 
on the principle that a larger molecule will have a greater 
distribution of surface charge than a smaller species. 
Electrophoresis in the presence of sos separates wholly according 
<"-' 
to molecular size (Reynolds and Tanford 1970), as expressed by the 
Stokes radius of the molecule, the charge differences being 
effectively screened by the presence of the -detergent. It thus 
appears that the mucosa contains two transferrin species of 
unequal size. The fact that the "odd" transferrin has a larger 
molecular weight or size than the "normal" variety would suggest 
that it is not a proteolytic degradation product. It is perhaps 
significant that neither purified serum transferrin _nor whole 
serum show this separation either on electrophoresis or on 
ion-exchange chromatography, where the protein .elutes as a single 
homogeneous peak (e.g. Sutton and Karp 1968). 
5.13.2. Isoelectrofocusing. 
Preparative column isoelectrofocusing of mucosal transferrin in 
the pH range of 5-7 yielded three transferrin peaks, as determined · 
by optical density, polyacrylamide gel electrophoresis and 
radioimmunoassay, at pH 5.2, 5.5 and 5.6 (Figure 32). This 
pattern corresponds to diferric, monoferric and apotransferrin 
(see above) respectively. Electrophoresis in the presence of SOS, 
however, showed no sepa~tion of the two transferrin fractions 
which showed parallel migration in all fractions (Figure 33). It 
appears therefore that charge and iron-binding do not acount for 
the differences in the transferrin species. Electrophoresis of 
clarified mucosal homogenates labelled in vivo with 59Fe, with or 
without a "cold" iron chase, followed by autoradiography, yielded 
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Figure 32. Column isoelectrofocusing of mucosal transferrin. The 
pH gradient used was 5-7. Optical density at 280nm <• e); pH 
( ~) and transferrin (A- - _.). 
-· 
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Figure 33. 6-8% sodium dodecyl sulphate polyacrylamide gel 
electrophoresis of isoelectrofocusing fractions of mucosa! 
transferrin. · 
The molecular weight markers, phophorylase b (MW 94000), albumin 
(MW 67000) and ovalbumin ~MW 43000) are in lane l; purified rat 
serum transferrin in lane 2, followed by the isoelectrofocusing 
fractions. 
Although the fractions are contaminated by the presence of other 
proteins, the two forms of mucosa! transferrin (marked with 
arrow) can be clearly seen. 
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mucosal transferrins, although the iron was present as free iron 
or on ferritin, not on the serum transferrin marker. It is thus 
supposed that the running conditions adversely affect iron-binding 
by the protein. To sum up, the presence of the two transferrin 
species appears to be a unique property of the mucosa and that the 
fractionation of •mucosal transferrin• in this way may be due to 
structural differences in the protein. Isoelectrofocusing, which 
fractionates according to iron content, indicated that iron 
binding was not responsible. The nature of the difference or 
differences remains to be determined. Possibilities are a 
difference in the carbohydrate moieties, although the 
immunological distinction would suggest a difference in primary or 
perhaps tertiary structure, both ~f which would account for the 
observed molecular size difference. 
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6. DISCUSSION. 
The demonstration of the gradient of absorption, with maximal 
absorption occurring in the proximal 10-lScm of intestine, 
confirms previous reports (e.g. Duthie 1964; Wheby et al 1964) and 
validates the isolated loop method use~ in this study. Identical 
pH conditions were maintained in ~11 incubation media and the iron 
was present as the soluble ferrous ascorbate complex, refuting the 
suggestion (Kavin et al 1967) that the low intraluminal pH of the 
duodenum, contributing to the maintenance of iron salts in 
solution, is responsible for the gradient of absorption and 
substantiating the results of Manis and Schachter (1966) and 
Greenberger et al (1967) with everted intestinal sacs. It bas 
also been suggested (Booth 1967) that a longer transit time in the 
' ileum may increase absorption; it was found here, however, that 
prolonging the incubation time to 4 hours had little effect. 
These factors suggest that the enhanced absorptive capacity of the 
duodenum is a property of the mucosa, and that a transport 
mechanism present in the duodenum is lacking in the ~leum (see 
below). In contrast to the absorption gradient, measured by blood 
and carcass activity, uniform adsorption or non-specific binding 
of iron occurred in all regions of the intestine. Iron uptake by 
isolated cells showed a rapid initial adsorption that may be 
related to the uniform mucosal uptake of washed loops of bowel 
(Savin and Cook 1978). This may represent tight binding on the 
membrane or deeper structure or even internalisation of the iron. 
A clear distinction may therefore be made between, firstly, uptake 
into or adhesion onto the cell of iron and, secondly, absorption 
or the transfer of iron across the mucosa to the bloodstream 
(Turnbull 1974). 
Similar kinetics of absorption with maximal uptake occurring 
between 30 and 60 minutes was shown by both blood and carcass as 
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well as isolated cells, and confirms the results of Savin and Cook 
(1978) on isolated cells and Kimber et al (1973) on brush borders. 
The finding that uptake by cells was partially inhibited by 
cyanide and low temperature concurs with the observation of 
Greenberger et al (1969) and Savin and Cook (1978) and suggests 
that the initial uptake step after binding to the membrane is at 
least partially energy-dependent. The similarity of uptake by 
cyanide- and EDTA-treated cells .as well as the effects obtained 
after addition of cyanide during incubation i.e. an immediate 
reduction of uptake, might, however, suggest that the iron is 
being removed from the system and would support Savin and Cook's 
(1978) hypothesis that the former is acting as a chelator of iron 
rendering the metal unavailable for · absorption. The initial rapid 
uptake of iron would presumably correspond to the •rapid 
absorption phase• described by Bothwell and Finch (1962) which is 
followed by a slow phase lasting up to 24 hours. The essential 
cessation of absorption after 60 minutes with minimal further 
uptake would suggest saturation of the mechanism. Increasing the 
amount of iron in the incubation medium, both in vivo and in 
vitro, resulted in linear increase in the amount taken up. This 
confirms the results of, for example, Wheby et al (1964) and 
Thomson and Valberg (1972). For all the iron doses, saturation 
time was the same, similarly in iron deficient and loaded animals. 
These results suggest that a time-related mechanism may be 
operative. An interesting observation from the literature is that 
competition exists between iron and other transition metal ions, 
such as cobalt (Thomson et al 1971). The evidence, thus, is as 
follows: the uptake mechanism is apparently time-dependent and 
relies on adsorption to the membrane; it is only partially 
inhibited by respiratory poisons such as cyanide and arsenate, but 
wholly by cytoskeletal poisons such as colchicine, vincristine and 
cytochalasin-B. Uptake is .diminished by the presence of a charged 
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iron chelator, EDTA, in the lumen, but, as is very well documented 
in the literature, enhanced by the more lipophilic neutral 
complexes such as ascorbate, certain sugars and amino acids (Davis 
and Deller 1967; Bates et al 1972). It should be mentioned here 
that ferritin loading was found to correlate exactly with 
absorption in terms of the specific activity of the protein, and 
thus may be used as an index of absorption. Investigation of the 
iron transport across membranes has shown that the more lipophilic 
the iron complex the better it is absorbed (Princiotto et al 
1964). Similar results have been found in intestinal absorption 
(Princiotto et al 1970; Edwards et al 1974). The importance of 
the maintenance of luminal iron in soluble form must also not be 
forgotten nor the fact that absorption occurs in the duodenum 
only, in spite of the satisfaction of this requirement. The 
results are not compatible with mechanisms of either active 
transport or simple diffusion, as has been suggested (e.g. Manis 
and Schachter 1962; May et al 1978). Most semipermeable 
membranes, including those surrounding cells, are not endowed with 
active transport mechanisms for transition metal ions (May et al 
1978), this theory has been discounted for various other reasons 
described in the Introduction, and is not compatible with the 
observation that absorption continues in spite of treatment with 
cyanide and arsenate. The mechanism of simple diffusion for iron 
absorption has in recent years attained some popularity (e~g. 
Savin and Cook 1978). However, although the partial inhibition by 
cyanide can be explained on the basis of chelation, as did these 
authors, the temperature- and hence energy-dependence of uptake 
would argue against this; similarly the linear increase in uptake 
with increasing iron dose would suggest simple diffusion, but does 
not explain the saturation effect after 30 minutes. The reliance 
of effective absorption on membrane-compatible and lipophilic iron 
complexes, as well as the necessity for soluble low molecular 
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weight iron would suggest diffusion, but can be explained in terms 
of other mechanisms. Lastly, and most important, th~ dependence 
of absorption on an intact cytoskeleton effectively rules out 
simple diffusion as a mechanism since this should be independent 
of cytoskeletal activity. The evidence is thus consistent with a 
mechanism of pinocytosis. During pinocytosis substances may be 
captured in two ways: they may be taken up in solution, so-called 
fluid-phase pinocytosis, or alternatively, they may be carried 
into the cell attached to the invaginating plasma membrane 
(Jacques 1969) or by a combination of the two, with the possible 
participation of specific receptors. Sugars and amino acids are 
taken up by facflitated diffusion (Pratten et al 1981). There is 
controversy as to whether all pinocytic processes are or are not 
energy-dependent; a classification depending on vesicle size was 
presented by Allison and Davies (1974) but does not seem 
definitive. Certainly the evidence presented here, such as 
partial energy-dependence -- the invagination of the membrane is 
energy-dependent-- and complete cytoskeletal dependence, would 
argue in favour of a pinocytic mechanism. Colchicine and 
vincristine are microtubule inhibitors, while the cytochalasins 
are inhibitors of microfilament function: both are implicated in 
pinocytic processes (Allison and Davies 1974) and indeed both have 
been implicated in the pinocytosis of transferrin (Galbraith and 
Galbraith 1980b). Pinocytosis is dependent on membrane function 
and movement, which would account for the dependence of effective 
absorption on the membrane-compatability of complexes. The 
ratelimiting step in all pinocytic phenomena is the number of 
pinosomes formed per unit time (Pratten et al 1981); little is 
known as to how this is controlled, but this might account for the 
cessation of absorption after 30 minutes, especially if a 
non-recycled ligand or receptor is involved. Furthermore, the 
presence of absorption in the duodenum only, in spite of identical 
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pH and solubility conditions maintained in the ileum, argues 
against simple diffusion and in favour of the presence of a 
specific mechanism. 
Fractionation of the labelled mucosa! homogenates indicated the 
presence of two iron-binding proteins only: ferritin and 
transferrin. This confirms previous findings (Batey and Gallagher 
1977; Halliday et al 1976; Huebers et al 1972; Savin and Cook 
1980). No evidence was found of the high molecular weight 
non-ferritin protein reported by Pearson and Reich (1969) and 
Worwood and Jacobs (1971), nor was evidence found of association 
of iron with the mitochondria (Hopkins and Peters 1979). In all 
cases and under all conditions, transferrin was found to label 
with iron, whereas ferritin labelled only in cells through which 
absorption was occurring. In in vitro-labelled cells, only a 
small amount of iron accumulated in ferritin: this may be result 
of the polar nature of mucosa! cells and the need for correct 
orientation to the iron, and thus may only in this respect be 
non-physiological. Fractionation of cells treated with 
cytoskeletal poisons showed labelling of transferrin only. Such 
indiscriminate uptake of iron by transferrin suggests that this 
labelling may be an artefact. As the mucosa! iron-binding proteins 
showed different immunological reactivities compared with those 
with which the radioimmunoassays were standardised, the protein 
concentrations obtained are not quantitative. The values 
obtained, however, fall within the same range as those reported by 
Savin and Cook (1980) using an immunoradiometric assay and 
Osterloh and Forth (1981) using radial immunodiffusion. The 
problem of the quantitation of mucosal-specific transferrin was 
partially overcome by estimating the possible serum contribution 
to the mucosal preparation. In spite of the differences in 
reactivities of serum and mucosal transferrin, a certain amount of 
transferrin was present in excess of any possible serum 
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contamination and an equivalent amount was shown to be 
inaccessible to proteolysis. While the "free" transferrin was 
present in equal quantities and showed identical iron-binding 
behaviour throughout the intestine,the membrane-associated protein 
showed a close correspondence to ~bsorption, whether under normal 
conditions or modified by position in intestine, iron status or 
cytoskeletal inhibitors. Colchicine and vincristine disrupt the 
microtubules of the cell, the former binding non-covalently to the 
tubulin subunits preventing assembly and creating conditions 
favouring dissociation (Taylor 1965) while vincristine 
precipitates and hence disrupts microtubules (Wilson et al 1970). 
The cytochalasins, including cytochalasin-B, are inhibitors of 
microfilament function: their effect is immediate and reversible 
even after long periods of incubation (Carter 1967) in contrast to 
the progressive effects of the microtubular inhibitors (Taylor 
1965). Both the immediacy and reversibility of effects of 
cytochalasin-B and the progressive effects of colchicine and 
vincristine were observed in this study. Dose ranges of both 
colchicine and vincristine are similar to those reported by 
Hemmaplardh et al (1974) and the former are similar to those 
required for the binding of colchicine to tubulin from porcine 
brain (Owellen et al 1972). Microtubules are implicated in 
vesicle movement through cells (Dumont and Wallace 1972; Wessells 
et al 1971) and microfilaments have been implicated in receptor 
mobility in the membrane (Galbraith and Galbraith 1980b). At low 
temperatures, receptors are randomly distributed through the 
membrane; warming results in aggregation of the receptors to form 
a "cap" (Raff and De Petris 1973), the fate of which is either to 
be shed from the cell or internali~ed (Unanue and Karnovsky 1973). 
Galbraith and Galbraith (1980b) showed that cytochalasin-B 
significantly inhibited the "capping" process of transferrin 
receptors in human mitogen-activated lymphocytes and hence 
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transferrin uptake. Hemmaplardh et al (1974) showed iron uptake 
by reticulocytes to be inhibited by microtubule poisons, including 
colchiclne and vincristine. Both receptors (Cox et al 1979; 
O'Donnell and Cox 1982) and vesicles (Evans and Grace 1974; 
Eastham et al 1977; Marx and Aisen 1981) associated with iron 
transport have been observed. It thus seems probable that iron 
transport in the mucosa is depe~dent on vesicle movement _and in 
this respect the membrane-associated transferrin fraction may be 
significant. The role of the "free" transferrin is difficult to 
explain. This was found in all regions of the intestine, where it 
showed the same iron-binding behaviour during iron absorption and 
the same immunological reactivity. The latter finding, together 
with the demonstration that only approximately a quarter of this 
transferrin was serum-derived, indicate that it is a mucosal 
protein. Whether iron-binding by this species is an artefact or 
not is uncertain. Iron-binding occurs equally in all situations 
whether or not absorption is occurring; furthermore, there is the 
observation that during absorpti~n from the macromolecular iron 
source, iron polymaltose, which does not, unlike ferrous 
ascorbate, donate iron to transferrin (see Appendix 2), almost no 
binding occurred. The latter should not be taken as conclusive 
evidence; little is known about the mechanism of absorption from 
the polymaltose complex, although the · preliminary studies reported 
here as well as previously published work (Jacobs et al 1979) have 
shown that absorption occurs with the same efficiency as from 
ferrous ascorbate 
suggesting that at least part of the transport and 
regulatory pathway is common. The role in absorption of this 
transferrin is thus at present uncertain. 
Mucosa! ferritin, like mucosa! transferrin, is also 
immunologically different from the ferritins of other tissues. 
Unlike transferrin, this is not in itself significant: 
electrophoretic and electrofocusing differences between the 
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isoferritins of different tissues are well known (Drysdale 1974; 
Linder-Horowitz et al 1970; Powell et al 1974) and H~zard et al 
(1977) have shown immunological differences between human 
isoferritins from different tissues. The reason for the 
differences lies in subunit heterogeneity: the genome apparently 
codes for several species of ferritin protein. Ferritin, in 
contrast to transferrin, is present in great~r quantities in the 
iron-absorbing areas and only takes up iron in these areas. The 
observation that iron-binding by ferritin, unlike that of 
transferrin, is inhibited by the microtubule and microfilament 
poisons suggests that it is not an artefact. On this evidence 
alone, one might conclude that it ' is involved in absorption. 
However, the protein is present in greater quantities in iron 
loaded animals and decreases in iron deficiency, factors which 
would argue against its involvement. Further evidence was given 
by the homogenisation with cold iron studies: ferritin is 
accumulating, not transporting, iron. The protein would therefore 
appear to lie on a sidepath of iron absorption, serving as a sink 
for excess iron. · The greater concentration in iron-absorbing 
areas is probably the effect rather than the cause: exposure of 
cells to iron results in ferritin synthesis (Drysdale and Munro 
1966) and exposure of intestinal cells to iron in the lumen 
likewise results in ferritin synthesis within a matter of hours 
(Bernier et al 1970). Most ferritin synthesis was found to occur 
in the duodenum. Iron also enters the cells from the serosal 
pole, resulting in ferritin synthesis, although in this case there 
was no preference for the duodenum (Bernier et al 1970). Results 
from parenteral iron loading experiments and fractionation of the 
mucosa at various time · intervals suggested that the cells were 
incorporating their "ferritin apparatus" during their development 
in the crypts of Lieberkuhn as suggested by Crosby et al (1963). 
This, it was hypothesised, acted as the regulator of absorption; 
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Brittin and Raval (1970), however, found in iron-deficient rats, 
despite maximal intestinal ferritin levels induced by luminal iron 
administration, absorption continued ~ta greater rate than 
normal, suggesting that ferritin is not the regulator. The 
results presented here suggest that the crucial point in 
absorption, and the point at which regulation occurs, is at the 
site before iron incorporation into ferritin. 
The immunological difference· between mucosal and serum transferrin 
is highly significant. The presence of a •different" mucosal 
transferrin has been suggested by a number of workers: Halliday 
et al (1976) who suggested that there might be an immunological 
differ~nce, Huebers et al (1976) who forind a transferrin different 
in pI -- this was not confirmed here-- and amino acid composition 
in the mucosa of the rat, and Pollack and Lasky (1976) who found a 
physically and immunologically distinct transferrin in the mucosa 
of the guinea pig. The demonstrated immunological difference 
might be due to several factors; firstly, proteolysis. This was 
extensively controlled and tested for: cells were washed and 
homogenised in the presence of proteolytic inhibitors as soon as 
removed from the gut and the radioimmunoassay was run on mucosal 
homogenates in the presence and absence of various factors 
including proteolytic inhibitors, detergent and buffers. No 
differences at all were found. Further, the polyacrylamide gel 
electrophoresis of the mucosal transferrin, showing a 
slower-moving, hence larger, species than the serum, would argue 
against proteolytic degradation. One is therefore forced, in the 
absence of extraneous factors, to conclude that the mucosal 
protein is a structurally different transferrin. The separation of 
mucosal transferrin into two major electrophoretic bands is 
apparently unique. Fractionation of transferrin into two or more 
fractions has been reported: Jeppsson and Sjoquist (1963) found 
separation of human diferric transferrin into two fractions on 
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CM-cellulose, Lane (1971) reported separation into three peaks on 
anion-exchange chromatography, according to iron con~ent and 
Huebers et al (1976) reported the electrophoretic fractionation of 
serum transferrin into two species, transferrin slow and 
transferrin fast. These results are not comparable to those 
obtained in this study however; with the exception of the 
last-named report, none of the fractions were electrophoretically 
distinguishable; with respect to the last-named report, no 
fractionation of serum transferrin was found in the present study. 
The reported results do show that heterogeneity within a single 
transferrin species may exist. This has also been reported under 
other circumstances e.g. Van Eijk et al (1982). Variations in 
carbohydrate composition among members of the transferrin class 
are fairly well-known (e.g. Parker and Bearn 1962; Wenn and 
Williams 1968); it is unlikely however that such differences would 
account for an immunological difference: antigenic determinants 
exist on the polypeptide backbone, not on the carbohydrate 
moieties. This however remains to be investigated. 
The remaining possibilities are those of differences in primary 
and tertiary structure. The former . would be due to an intrinsic 
difference in the polypeptide backbone in terms of the number of 
amino acid residues or the composition of the sequence, and would 
imply a separate gene product. Purification and sequencing of 
mucosal transferrin is at present being carried out in this 
laboratory. A difference in tertiary structure, or the 
conformation of the protein, could produce an immunological 
difference by shielding of the antigenic determinants during 
folding, and the molecular size difference by the compactness of 
the folded structure. If this is so, and the mucosal species 
represents a different conformational state, the major or one of 
the major, differences between serum and mucosa! transferrin is 
the ability of the latter to exist in a different stable 
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conformational state. This would be in itself a very interesting 
phenomenon, and one that is apparently rare in proteins (Creighton 
1979), although such stable conformational intermediates have been 
reported for cytochrome c (Myer 1968), bovine a-lactalbumin 
(Kuwajima et al 1976), bovine carbonic anhydrase B (Wong and 
Tanford 1973) and Staphylococcus aureus penicillinase (Carrey and 
Pain 1978). It is known that iron binding to transferrin induces 
conformational changes (Kornfeld 1969; Charlwood 1971). Iron 
binding, as described in the Introduction, involves a number of 
ligands not all in the same position on the molecule, hence 
binding of an iron atom presupposes the assumption of a more 
folded, spherical and compact configuration to accommodate the 
metal. This could very well result in the shielding _of antigenic 
sites, hence the difference in immunoreactivity. However,the 
evidence is against this: in vitro addition of iron, as FeIII-NTA 
to serum transferrin resulted in no change in immunoreactivity, 
nor could the sera of iron deficient and loaded rats be found to 
show an immunological difference. Isolelectrofocusing of mucosal 
transferrin preparations, both whole homogenates and partially 
purified protein, resulted in no immunological difference between 
the fractions; it is concluded therefore that the immunological 
difference is not a result of differing iron content. It is 
interesting to speculate on why such a structural or 
conformational difference between serum and mucosal transferrin 
might exist. The problem of iron uptake by reticulocytes and 
other cells is one that has puzzled investigators for many years: 
it is known that transferrin binds to the membrane and is 
apparently interna~ised (e.g. Sullivan et al 1976) before 
releasing the iron and returning to the serum. Most of the early 
studies e.g. Jandl et al (1959), Kornfeld (1968), Alsen et al 
(1966) were performed with human transferrin and rabbit 
reticulocytes, and a significant difference was found between 
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uptake from diferric and monoferric transferrin. Later studies 
using homologous systems of rabbit-rabbit and human-human 
transferrin and reticulocytes respectively e.g. Esparza and Brock 
(1980) and Huebers et al (1981) could not repeat these findings, 
and on this basis the Fletcher-Huehns hypothesis was discounted 
(Van der Heul et al 1982). It is known that the binding sites of 
transferrin show spectral and iron affinity differences as well as 
differences in · their susceptibility to modification (Kornfeld 
1968) and the protein undergoes conformational changes induced by 
iron binding. It is thus suggested that in the case of the 
heterologous human-rabbit situation, enhanced binding of diferric 
transferrin to the membrane, resulting in enhanced uptake of iron 
by the celf binding to the membrane is inevitably followed by 
endocytosis of the transferrin regardless of its iron content 
(Baker et al 1982) -- is a result not of its iron content but of 
its conformational state. It is known that, generally, alteration 
in tertiary structure causes modification of molecule-receptor 
interaction (Pratten et al 1981) but little is currently known 
about such interactions. In other words, the receptor in this 
non-physiological situation is recognising some facet of the 
transferrin's conformation; that this conformation is also 
associated with iron binding is coincidental. In this respect, 
Kornfeld (1968) using various reagents to modify the biological 
properties of transferrin, found that, regardless of reagent used, -
interaction of transferrin with reticulocytes was more sensitive 
to chemical modification than the ability to bind iron, suggesting 
that these are two separate events. Mucosal transferrin is clearly 
very closely related to serum transferrin and there is no reason 
to believe that its behaviour should be radically different. The 
Fletcher-Huehns hypothesis proposed that different affinity of 
binding sites of transferrin for different tissues was responsible 
for body iron regulation. The hypothesis has, for reasons 
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described previously, fallen into disfavour. However, it is 
possible that, as far as iron absorption is concerned, the 
hypothesis may not be too far wrong, that transferrin may act as 
the regulator of iron absorption, but that regulation may occur 
not as result of differential iron binding, as proposed by _ 
Fletcher and Huehns, or by the conformational states thus induced, 
but by an alteration in conformational state. This is purely 
hypothetical. 
The question of iron absorption has been intensively studied for 
close on twenty years, both physiologically and biochemically, but 
little concrete evidence as to the mechanism of absorption has 
emerged. This is very probably due to intrinsic proble~s 
associated with the fractionation of the mucosa, particularly 
cross-contamination of fractions ( Hopkins and Peters 1979). This 
problem was encountered here also, and renders conclusions as to 
the mechanism of absorption difficult to draw. No small high-flux 
compartment that might be associated with a carrier pool could be 
identified; furthermore, it is uncertain whether the low molecular 
weight compound or even iron-binding by transferrin itself, are 
artefacts, the results of cross-contamination. It does appear, 
however, that a cytoskeletal-dependent transport mechanism is 
operative; the possibility of brush border vesicles in iron uptake 
has been suggested (Evans and Grace 1974; Eastham et al 1977) but 
this study is apparently the first in which absorption has been 
shown to be dependent on the function of microtubules and 
microfilaments. 
Transferrin and ferritin were quantitated, as far as possible 
allowing for the differences in immunological reactivity between 
the mucosa! proteins and those with which the assays were 
standardised. The role of ferritin can be explained with 
reasonable certainty, the role of transferrin less so. The 
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finding of an immunologically and electrophoretically distinct 
mucosal transferrin species is significant and further 
investigation into the structure and function of this protein is 
under way. It is tempting to postulate that this transferrin 
represents the carrier and/or regulator of absorption, but the 
possibility remains that its iron-binding activity under the 
conditions of absorption represents an artefact. It is also 
tempting to postulate,in vi•w of both its demonstrated partial 
membrane-association and larger molecular size that it may be 
homologous to p97 that has recently been shown to be a member of 
the transferrin class (Brown et al 1982). It has recently been 
proposed (Williams 1982) that p97 may represent an evolutionary 
intermediate in the development of transferrin: it is almost 
certainly true, in view of the close sequence homology between the 
two domains (MacGillivray et al 1982) that gene duplication 
occurred during transferrin's evolution, and that the ancestral 
protein had a mo1ecular weight of approximately 40000. The small 
size would have resulted in excretion through the kidney as has 
been demonstrated for 40000 molecular weight fragments of 
transferrin (Williams et al 1982) necessitating anchorage of some 
sort, hence the proposal of a membrane-associated form. Mucosal 
transferrin is found partially in association with membrane and 
furthermore is located within the mucosal cells, rather than in 
the serum and thus subject to renal excretion. It is thus 
possible that mucosal transferrin may represent an intermediate 
stage in the evolution of the transferrin class. 
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8. APPENDICES 
8.1. Appendix 1. 
8.1.1. Viability of intestinal loops. · 
The rat was anaesthetised with Sagatal, the abdomen opened and a 
5cm loop ligated in the duodenum. Ligatures were removed after 30 
minutes and the abdomen was sutured. After 5 hours, the loop was 
again ligated and the radiolabelled ferrous ascorbate solution 
injected. After 30 minutes the animal was sacrificed and the 
mucosa! cells from the loop harvested and fractionated on a 10-50% 
sucrose density gradient. The iron-binding profile of this cell 
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Figure. Density gradient fractionation of cell homogenate from an 
intestinal loop, ligatured for 30 minutes, allowed to recover for 
5 hours, re-ligatured and the ferrous ascorbate solution injected. 
It can be seen that uptake of iron into ferritin has occurred, 
indicating that normal absorption is taking place. 
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8.2. Appendix 2. 
8.2.1. Iron Polymaltose. 
8.2.1.1. Iron release from iron polymaltose 
Total Cpm 60 min. 120 min. 180 min. 
Control 43900 13 14 28 
+ Amylase 43814 15 8 9 
Gut - inhib 43204 25 25 27 
Gut+ inhib 43367 4 4 8 
+ Succus 43204 19 15 11 
Ase.* 43663 39 38 42 
EDTA* 42436 138 215 308 
Tf* 42851 19 21 54 
Ferri tin* 42333 16 39 53 
Table. Iron release from iron polymaltose in the presence of 
various agents. Amylase (200µ1 saliva), cells from 5cm intestinal 
segments, homogenised with and without proteolytic inhibitors (see 
Methods for details), and succus entericus (200µ1 washing from the 
duodenum) were incubated together with 3µg iron as iron 
polymaltose, in 10ml 5mM Tris/HCl, pH 7.4 buffer, in a dialysis 
bag. This was dialysed against 20ml of the same buffer with 
shaking at room temperature. At specified time intervals, 10ml 
In a second experiment (*), 0.4mM ascorbic acid, 5mM EDTA, 10µg 
rat serum transferrin and 10pg rat liver ~erritin were present in 
the 20ml of buffer, rhe dialysis bags contained 3µg iron as iron 
polymaltose in 10ml buffer only • . At specified time intervals, 
10ml aliquots of buffer were removed, counted for 59Fe activity 
and replaced. 
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s.2.1.2. Comparison of absorption 
The absorption from salt and from polymaltose was investigated by 
comparing absorption from differently labelled salt and 
polymaltose as follows: after overnight fast, animals received an 
oral dose by nasogastric tube of 3pg iron as either ferrous 
ascorbate or. iron polymaltose. Each form of iron was labelled 
with a different isotope. Thereafter no food was allowed for the 
following 4 hours. The following day, under comparable conditions 
of fasting, the second compound, labelled with the other isotope, 
was given. After 2 weeks, when it was estimated that optimal 
incorporation of iron into haemoglobin had occurred,the rats were 
venesected by cardiac puncture under ether anaesthesia and the 
blood collected in anticoagulant. 2ml aliquots of blood with 
addition of 5mg iron as carrier were digested by the method of 
Katz et al (1964). Aliquots of the orally administered iron doses 
were retained, diluted to approximately expected blood 
concentrations and treated in the same manner as the blood 
samples. 5~Fe and S9Fe activities were determined simultaneously 
as described in Methods. The amount of iron absorbed was . 
calculated on the assumption that 100% of the retained 
radioactivity was present in the haemoglobin of circulating red 




Iron deficient 10 
Iron loaded 10 
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Table. A comparison of absorption from ferrous ascorbate 
(column 3) and iron polymaltose (column 4). There is no 
significant difference between the respective percentage 
absorptions for salt and polymaltose in each group (p>0.05). 
